Annual Meeting American Academy Of Dental Sleep Medicine

DEAR AADSMANNUAL MEETINGATTENDEES:As Chair of the AADSM Annual Meeting Committee, I welcome you to the AADSM21st Annual Meeting.The 2012 program provides educational courses for all experience levels, including a newcourse for clinicians and auxiliary staff and a new course for those interested in takingthe ABDSM Diplomate exam. We have also increased the number of meet the professorsessions from six to nine. We’re thrilled to make these additions to the program toaccommodate the growth of the meeting and the field of dental sleep medicine.We are pleased to offer two session tracks at this year’s meeting to give you more optionsto hear about different topics. As such, some session times feature two educational sessionsmeeting in two different rooms so that you may customize your schedule accordingly.This year’s meeting will also feature poster and oral abstract presentations, with theResearch Committee announcing this year’s research winners at the start of the generalsession on Thursday afternoon, as well as a number of invited lecturers, symposia anddiscussion groups on clinical topics and the latest research.It is the hope of the Annual Meeting Committee that you are able to both renew and initiaterelationships with colleagues from around the world while expanding your knowledge ofdental sleep medicine.Sincerely,TABLE OF CONTENTSLeslie C. Dort, DDSChair, Annual Meeting CommitteeWelcome................................................................................... 2Annual Meeting Committee .................................................... 2General Information ................................................................ 4Continuing Education Information ......................................... 5Learning Objectives ................................................................ 5Schedule at a Glance ............................................................... 6Sheraton Boston Map .............................................................. 7Invited Lecturers ....................................................................10Educational Courses .............................................................. 13General Session ......................................................................14President’s Reception ............................................................. 20Exhibitor Listing .................................................................... 23Abstracts ................................................................................ 29Speaker Index ......................................................................... 422012 ANNUAL MEETING COMMITTEELeslie Dort, DDS, Diplomate, ABDSMChair, Annual Meeting CommitteeFernanda Almeida, DDS, PhD, Diplomate, ABDSMDonald Falace, DMDHowell Goldberg, DDS, Diplomate, ABDSMB. Gail Demko, DMD, Diplomate, ABDSMBoard LiaisonSheri Katz, DDS, Diplomate, ABDSMAADSM President2 We Want Your Feedback | Visit www.aadsm.org/evaluations

Join the ConversationInclude #AADSM2012 as part of each Tweet you send from BostonSearch #AADSM2012 on Twitter.com to follow the conversationFollow the AADSM @AADSMorgFacebook.com/AADSMorg#AADSM2012AMERICAN ACADEMY OF DENTAL SLEEP MEDICINE PRESENTSINTRODUCTION TO DENTAL SLEEP MEDICINECourse Chair: R. Bruce Templeton, DMDOCTOBER 27-28, 2012 | LAS VEGAS, NVADVANCED DENTAL SLEEP MEDICINECourse Chair: Michael Simmons, DMDOCTOBER 27-28, 2012 | LAS VEGAS, NVPRACTICE MANAGEMENT new add-on course!Course Chair: Lydia Sosenko, DDSOCTOBER 28, 2012 | LAS VEGAS, NVTHESECOURSESHAVE BEENAPPROVEDFOR ADACERP CREDIT.Learn about dental sleep medicine, particularly oral appliance therapy for snoring and obstructive sleep apnea andhow you can incorporate it into your dental practice. Visit the course exhibit hall to speak with industry experts aboutnew products and services. For more information and to register, please contact the AADSM atwww.aadsm.org or call (630) 737-9761.The American Academy of Dental Sleep Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American DentalAssociation to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve orendorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.We Want Your Feedback | Visit www.aadsm.org/evaluations3

GENERAL INFORMATIONLocationThe AADSM 21 st Annual Meeting is held Thursday, June 7 –Saturday, June 9, 2012, at the Sheraton Boston Hotel in Boston,Massachusetts.Sheraton Boston Hotel39 Dalton StreetBoston, Massachusetts 02199Phone: (617) 236-2000Registration HoursThe on-site registration hours at the Sheraton Boston are:Thursday, June 7 6:30am – 5:30pmFriday, June 87:00am – 6:00pmSaturday, June 9 7:00am – 5:00pmThe registration desk is located on the 2nd floor.Your registration includes admission to:• General Sessions (Thursday afternoon – Saturday)• The President’s Reception• Industry Supported Events• Exhibit HallNote: Educational courses and meet the professor sessionsrequire additional fees.Guest PassesA registered attendee may elect to buy a guest pass. These guestpasses are for family members only and allow entrance to theexhibit hall. Guests are not allowed to attend any of the generalor ticketed sessions. Children under 16 years of age are notpermitted in the exhibit hall.Badge InformationAll meeting participants and guests must wear a badge. Badgesdetermine entrance to the general sessions and exhibit hall.Your cooperation with this policy is appreciated.Exhibit HallThe exhibit hall showcases booth displays of dental laboratories,appliance inventors and others. The exhibit hall is located in theBack Bay Ballroom. Exhibit hall hours are:Thursday, June 7 7:00am – 5:30pmFriday, June 87:00am – 5:30pmSaturday, June 9 7:00am – 3:45pmBoston TourismFor information on Boston, contact the Greater BostonConvention & Visitors Bureau via phone at (617) 424-4100 ortheir visit website at www.bostonusa.com.We Want Your FeedbackAll attendees are encouraged to evaluate eachsession they attend throughout the conference. Visitwww.aadsm.org/evaluations at any time during the meeting torate the sessions. The site will close on June 15, 2012.The sole purpose of this site is to evaluate speakers and sessionsthat you attend at the AADSM Annual Meeting. The AnnualMeeting Committee will use this information to plan futureevents. To claim credits from the meeting, complete and submitthe credit claim form to the registration desk before you leavethe meeting. The deadline to claim credit is October 1, 2012.Photography/RecordingPhotography and/or recording of any kind, other than by theAADSM or registered press approved by the AADSM, of sessions,speakers and the exhibit hall is prohibited. No cameras will beallowed on the exhibit floor or in the meeting rooms at any time.Violation of this rule could result in the confiscation of the film orrecording device and removal of individual from the meeting.Society InformationDetails about membership and products from the AmericanAcademy of Dental Sleep Medicine are available at theregistration desk located on the 2 nd Floor in the Ballroom Foyer.Hotel InformationQuestions regarding housing for the AADSM 21 st AnnualMeeting should be directed to:AADSM Housing Bureauc/o OnPeak350 N. Clark Street, Suite 200Chicago, IL 60654Phone: (866) 611-8832E-mail: sleepmedicine@onpeakevents.comPrudential Center “PRUferred Card”The Prudential Center is connected to the SheratonBoston Hotel and offers many shopping and diningoptions for meeting attendees. AADSM attendeesmay take advantage of discounts at the PrudentialCenter by visiting the Customer Service Desk inCenter Court of the Prudential Center to get their cardfor free!For a list of all the discounts on the PRUferred card,please visit their website:www.prudentialcenter.com/save/pruferred.php4 We Want Your Feedback | Visit www.aadsm.org/evaluations

CONTINUING EDUCATIONContinuing Education Credit Hours (CE Hours)American Academy of Dental Sleep Medicine (AADSM) is anADA CERP Recognized Provider.ADA CERP is a service of the American Dental Associationto assist dental professionals in identifying quality providersof continuing dental education. ADA CERP does not approveor endorse individual courses or instructors, nor does it implyacceptance of credit hours by boards of dentistry.American Academy of Dental Sleep Medicine (AADSM)designates this activity for 22.25 continuing education credits.The AADSM 21 st Annual Meeting is open to all dentists,physicians, scientists and other health care professionals whotreat or have an interest in treating patients with sleep relatedbreathing disorders. The AADSM Program will be presentedthrough lectures, panel discussions, open discussions anddemonstrations.The AADSM 21 st Annual Meeting sessions teach participantsa basic knowledge of dental sleep medicine; a knowledge ofthe epidemiology and pathophysiology of obstructive sleepapnea (OSA) in adults and children; new diagnostic tests forOSA; understanding of the use of mandibular repositioningand tongue retaining devices in the treatment of OSA; and aknowledge of surgical options in the treatment of OSA.Target Audience:The program of the AADSM 21 st Annual Meeting is intendedfor dentists and dental professionals who are currently treatingpatients with obstructive sleep apnea or snoring through theutilization of oral appliance therapy. The AADSM 21 st AnnualMeeting is also intended for dentists, physicians, and dentalprofessionals who are seeking an in-depth introduction to dentalsleep medicine and oral appliance therapy.AADSM 21 st Annual Meeting Learning Objectives:• Acquire knowledge about the management ofobstructive sleep apnea in both adults and children;• Discuss state-of-the-art knowledge of recent advancesin dental sleep medicine and sleep apnea treatment;• Review the relationship between obstructive sleepapnea, cardiovascular disease and other associated comorbidities;• Understand the evidence regarding long-term oralappliance therapy, including potential side effects andoptions for managing complications in patients withsnoring and/or OSA; and• Apply best practices for building and developing asuccessful dental sleep medicine practice, includingan overview of proper patient management anddevelopment of care plans; creating awareness aboutsleep related breathing disorders and their treatments;positioning your practice as a provider of dental sleepmedicine; and proper medical insurance billing.To review speaker conflicts, visit www.aadsm.org.LEGENDEducational Courses — Intensive reviews of topicspresented in a half-day session format prior to thegeneral session.Discussion Groups — Forums for informal presentationsof a specific topic, which may include conversationson controversial subjects or pro/con discussions andpresentations.Invited Lecturers — One-hour lectures during whichsenior level investigators/clinicians present in theirareas of expertise.Meet the Professors — Small-group lunch sessionsduring which an expert in the field leads an informaldiscussion on a single topic.Oral Presentations — 15-minute presentations duringwhich investigators present their latest research andnew ideas in the field.Poster Presentations — Visual representations of thelatest research and new ideas in the field.Symposia — Sessions focusing on the latest data andideas in the field.Clinical Workshops — Reviews of the latest clinicalchallenges. Workshops include presentations ordiscussions of controversial clinical topics or difficultclinical situations that demonstrate the critical thinkingprocess in dental sleep medicine.We Want Your Feedback | Visit www.aadsm.org/evaluations5

SCHEDULE AT A GLANCE* Continental breakfast and refreshment breaks will be offered to attendees on each day of the meeting. All other meals are the responsibility of the attendee.Thursday June 7, 2012Registration Open 6:30am–5:30pm Exhibit Hall Open 7:00am–5:30pm8:00am–12:30pm 01 - Grand Ballroom 02 - Republic Ballroom 03 - Constitution A 04 - Constitution B12:30pm–1:30pm1:30pm–2:15pm2:15pm–3:30pm3:30pm–5:30pm01: Dr. Olivier VandervekenExeter Room02: Dr. Barbara FisherDalton RoomIntroduction, Awards and Keynote AddressGrand Ballroom03: Dr. B. Gail DemkoHampton AB01: From CPAP to Oral Appliance Therapy: Lessons of the Past and Perspectives for the FutureGrand Ballroom01: Sleep Tests Part 1: PSG and Portable MonitorsGrand Ballroom6:00pm–9:00pm Industry Supported Events - Nierman Practice Management and ResMed (see page 15)Friday June 8, 2012Registration Open 7:00am–6:00pm Exhibit Hall Open 7:00am–5:30pm8:00am–9:00am 02: A Year in Review - Grand Ballroom9:00am–10:00am01: OSA: Hypoxia Effects on the BrainGrand Ballroom02: Bite RegistrationRepublic Ballroom10:30am–11:30am 03: Dental and TMJ Side-Effects of Oral Appliances - Grand Ballroom11:30am–12:30pm12:30pm–1:30pm1:30pm–2:30pm02: Emerging Treatments for OSAGrand Ballroom04: Dr. Nancy AddyExeter Room03: Dental Sleep Medicine Accreditation:Tips for an Efficient and Effective Accreditation ProcessRepublic Ballroom05: Dr. Lydia SosenkoDalton Room04: Adolescent Sleep–What is Normal / What is Not?Grand Ballroom06: Dr. Bruce TempletonHampton AB2:30pm–4:00pm 03: Pediatric Sleep - Republic Ballroom 01: Oral Abstract Presentations - Grand Ballroom4:30pm–5:30pm5:30pm–6:00pm6:30pm–8:00pmSaturday June 9, 201204: Compliance Monitoring in Oral ApplianceTherapy - Grand Ballroom01: Practice Building: Communication with the SleepPhysician - Republic BallroomAADSM General Membership & Business Meeting - Grand BallroomPresident’s Reception - Constitution BallroomRegistration Open 7:00am–5:00pm Exhibit Hall Open 7:00am–3:45pm8:00am–9:00am04: Sleep Testing Part 2: Confounding Conditions “Ambulatory Testing and PSG”Grand Ballroom9:00am–10:00am 05: The Human Circadian Timing System - Grand Ballroom10:30am–12:30pm 05: Appliance Selection – What Do We Know Today? - Grand Ballroom12:30pm–1:30pm07: Dr. Nancy AddyExeter Room08: Dr. Alan LoweDalton Room1:30pm–2:30pm 06: Stroke and Cardiovascular Consequences of OSA - Grand Ballroom09: Dr. Marie MarklundHampton AB2:30pm–4:00pm4:00pm–5:00pm06: Geriatric SleepGrand Ballroom08: Complicating Condition and OSAGrand Ballroom07: Hypoglossal Nerve Stimulation for OSA –TheState of the Art - Republic Ballroom05: Medicare Issues for Dental Sleep MedicineRepublic Ballroom6 We Want Your Feedback | Visit www.aadsm.org/evaluations

2013AWARDCOMPETITIONThe American Academy of Dental SleepMedicine (AADSM) promotes the researchof oral appliances (OA) and upper airwaysurgery for the treatment of sleep relatedbreathing disorders (SRBD) and providestraining and resources for those who work directly with patients.To fulfill its mission, the AADSM has an award competition toaward students, dentists, physicians, nurses, psychologists and otherspecialties who conduct research in studies related to dental sleepmedicine.GRADUATE STUDENT RESEARCH AWARD (GSRA)The Graduate Student Research Awards are for current and recentdental sleep medicine students(master/ PhD/ postdoctoral students/ residents). Applicants will berequired to submit an abstract through an application process afterwhich the research committee will select up to three finalists to presenttheir abstracts at the AADSM Annual Meeting.RESEARCH EXCELLENCE AWARDOut of the three finalists, one will be selected to receive the ResearchExcellence Award for having the most outstanding research project.CLINICAL RESEARCH AWARD (CRA)The Clinical Research Awards will be presented to clinicians,researchers or academicians in dental sleep medicine for outstandingresearch efforts. Applicants will be required to submit an abstractthrough an application process after which the research committeewill select up to three finalists to present their abstracts at the AADSMAnnual Meeting.CLINICAL EXCELLENCE AWARDOut of the three finalists, one will be selected to receive the ClinicalExcellence Awards for having the most outstanding research project.All applications and abstracts are due by Dec. 17, 2012. Applicationand information about the Awards is available at the AADSM Website,www.aadsm.org.RESEARCH COMMITTEEMarie Marklund, DDS, PhD, (Chair)Ghizlane Aarab, DDS, PhDFernanda Almeida, DDS, PhDBernard Fleury, MDAntonio Romero Garcia, DDSAarnoud Hoekema, DMD, PhDNelly Huynh, PhDGilles Lavigne, DDS, PhDAlan A. Lowe, DMD, PhDThomas Schell, DMDFlavia Sreshta, DDSSatoru Tsuiki, DDS, PhDOlivier Vanderveken, MD, PhD

INVITED LECTURERSFernanda R. Almeida,DDS, PhD, Diplomate,ABDSMI03: Dental and TMJ Side-Effects of Oral AppliancesFriday, June 810:30am – 11:30amRoom: Grand BallroomDr. Fernanda Almeida is anassistant professor at TheUniversity of British Columbia(UBC) Canada, and teaches oraland maxillofacial radiology and dental sleep medicine. She hasrecently been awarded the WW Wood Teaching Award for heroutstanding contributions to the educational progress of theundergraduate dental students at UBC. Dr. Almeida receivedher master’s degree from the Federal University of São Pauloand doctorate (PhD) at the University of British Columbia, bothin the field of dental sleep medicine. She also sees patients ina private practice restricted to the treatment of sleep relatedbreathing disorders. She leads the area of dental sleep medicinewith Dr. Alan Lowe and is part of the UBC sleep research team.She has published more than 35 peer reviewed papers and 4book chapters. Her research is focused on dental sleep medicine,involving oral appliance side effects on dentition and TMJ,compliance, titration modalities and treatment outcomes. Shealso researches on upper airway imaging; pediatric and geriatricsleep disorder breathing.Dr. Almeida is on the editorial board of the Journal of ClinicalSleep Medicine, and is an active reviewer for the journalsSLEEP, Sleep Medicine, Journal of Clinical Sleep Medicine,Angle Orthodontics, Chest, Thorax and JADA. She is anassociate editor of Sleep & Breathing.She is the current chair of the AADSM research committee,where she has been working on increasing the quantity andquality of research presented and awarded by the AADSM. Sheis the British Columbia representative dentist at the CanadianSleep Society and has been highly involved with policies andprocedures in dental sleep medicine practices.Douglas Bradley, MDI06: Stroke andCardiovascular Consequencesof OSASaturday, June 91:30pm – 2:30pmRoom: Grand BallroomDr. Bradley is Professor ofMedicine and Director of theCentre for Sleep Medicineand Circadian Biology at theUniversity of Toronto, theCardiopulmonary Sleep Disorders and Research Centre at theToronto General Hospital/University Health Network, andthe Sleep Research Laboratory at the Toronto RehabilitationInstitute. Dr. Bradley completed his MD degree at theUniversity of Alberta in Edmonton in 1978. Subsequently, hecompleted specialty training at the University of Toronto inInternal Medicine in 1982 and Respirology in 1985. Followingcompletion of clinical training he went on to 3 years of researchtraining in sleep apnea and respiratory muscle physiology atthe University of Toronto and McGill University, respectively.He has been on staff at the Toronto General Hospital at theUniversity of Toronto since 1985.Dr. Bradley’s clinical and research work focuses on therelationship between sleep apnea and cardiovascular diseases,with a particular focus on the pathophysiology and treatmentof sleep apnea in patients with heart failure. He holds severalpeer-reviewed grants from the Canadian Institutes of HealthResearch (CIHR), The Physicians’ Services Incorporated andthe Heart and Stroke Foundation of Ontario. He has publishedover 140 papers and book chapters on sleep apnea and relatedtopics. Dr. Bradley is a member of the American Societyfor Clinical Investigation and is an Associate Editor of theAmerican Journal of Respiratory and Critical Care Medicine,and is on the editorial board of SLEEP.10 We Want Your Feedback | Visit www.aadsm.org/evaluations

INVITED LECTURERSBernard Fleury, MDI01: From CPAP to OralAppliance Therapy: Lessons ofthe Past and Perspectives forthe FutureThursday, June 72:30pm – 3:30pmRoom: Grand BallroomDr. Fleury graduated from theFaculté de Medecine Saint-Louis Lariboisière, Paris,France in 1981. After a four-yearfellowship in pneumology in Paris and a postgraduate trainingin respiratory physiology at the Meakins Christie Laboratories(McGill University, Montréal), his interest became focusedon the treatment of sleep related breathing disorders. He iscurrently running the sleep disorders center of the HôpitalSaint Antoine, Groupe Hospitalier Paris-Est-Université Pierreet Marie Curie, Paris, France. He works closely with the ENTdepartment and with the orthodontics department of the faculty.He is engaged in research and publications focused on treatmentof obstructive sleep apnea in adults, CPAP therapy, surgery andoral appliances.Gila Lindsley, PhDI04: Adolescent Sleep – Whatis Normal / What is Not?Friday, June 81:30pm – 2:30pmRoom: Grand BallroomDr. Lindsley has a PhD inPhysiological Psychology fromthe University of Wisconsin, didher internship in sleep disordersmedicine at the Dartmouth-Hitchcock sleep disorders center,and is a fellow of the American Academy of Sleep Medicine.The founding director of one of the first sleep disorders centersin New England, established in 1983, she has maintained aprivate practice sleep disorders clinic in Lexington, MA since1992. She is a member of the Medical Advisory Board ofNarcolepsy Network with considerable interest in narcolepsy.Of particular interest to her are sleep disorders in a school agepopulation and circadian rhythm disturbances across the agespan. A recent focus has been on irregular breathing duringsleep, discriminating between those disturbances that are aproduct of obstructive sleep apnea syndrome and those whicharise due to a more basic problem with sleep physiology andwhich therefore point to a disorder different from obstructivesleep apnea.We Want Your Feedback | Visit www.aadsm.org/evaluations11

INVITED LECTURERSMarie E. Marklund, DDS,PhDI02: A Year in ReviewFriday, June 88:00am – 9:00amRoom: Grand BallroomDr. Marklund is AssociateProfessor of the Department ofOdontology, Medical Faculty,Umeå University, Sweden andis the head of the OrthodonticDepartment. She works incollaboration with the Sleep Apnea Clinic at the Department ofRespiratory Medicine, Umeå University Hospital. Her practicefocuses mainly on the treatment of patients with snoring andobstructive sleep apnea (OSA) with oral appliance therapy(OAT).The research interests of Dr. Marklund include treatmenteffects and side-effects of OAT. Recently she has focused on thesymtomatic and cardiovascular effects from OAT, the long-termoutcome and the management of side-effects. Prediction ofeffects and side-effects has been covered in her research. Shehas lectured extensively over the world and published manyarticles in the field of OAT for OSA, including bookchaptersand a recently published task force report for the EuropeanRespiratory Society.Phyllis C. Zee, MD, PhDI05: The Human CircadianTiming SystemSaturday, June 99:00am – 10:00amRoom: Grand BallromDr. Zee is Professor ofNeurology, Neurobiology &Physiology, and Director ofthe Sleep Disorders Centerand the sleep medicinefellowship training program,at Northwestern University’s Feinberg School of Medicine inChicago, Illinois, where she is also Associate Director of theCenter for Sleep and Circadian Biology.Dr. Zee directs an interdisciplinary clinical and researchprogram in sleep and circadian rhythms. Research topics inthis Program range from basic animal studies to therapeuticclinical trials. Her research has focused on the effects of ageon sleep and circadian rhythms, genetic regulation of circadiansleep disorders, and behavioral interventions to improve sleepand performance. In addition, current NIH-sponsored researchinclude studies that examine the relationship between sleepand sleep disorders with metabolic and cardiovascular risk inpopulations at risk, such as older adults, and the effects of sleepdisturbance on adverse pregnancy outcomes. Dr. Zee also hasauthored more than 100 peer reviewed original articles andover 40 chapters and reviews on the topics of sleep, circadianrhythms, and sleep/wake disorders.A fellow of the American Academy of Sleep Medicine, fellowof the American Academy of Neurology and member of theAmerican Neurological Association, Dr. Zee has served onnumerous national and international committees, NIH scientificreview panels, and advisory boards. She is President of theSleep Research Society, past Chair of the NIH Sleep DisordersResearch Advisory Board, and a Deputy Editor for the journalSLEEP. Dr. Zee is the recipient of the 2011 American Academyof Neurology Sleep Science Award.12 We Want Your Feedback | Visit www.aadsm.org/evaluations

EDUCATIONAL COURSES Thursday, June 7, 2012The educational courses in the morning on Thursday, June 7,2012, are not included in the general admission registration;all educational courses are additional fees and are ticketed. Ifthe educational courses are not sold out, tickets are availablefor on-site purchase at the registration counter. There arefour educational tracks to choose from. Total CE credit foreach course is 4.25. All educational courses will includecontinental breakfast and a morning refreshment break from10:00am – 10:15am.NewElectronic Meeting MaterialsIn its continued effort to “Go Green,” the AADSMprovided postgraduate course materials in an electronicformatonly. Attendees were provided with the materialson a thumb drive. Prior to the meeting, attendees whopre-registered were allowed to download and print thecourse materials. Please note that the AADSM will notsupply computers or tablets to view the material or powerfor computers or tablets. It is imperative that attendeeswishing to view the course materials on their laptops ortablets have them sufficiently powered prior to arrival atthe meeting each day.01: Advanced CourseTicketed Event8:00am – 12:30pmRoom: Grand BallroomOverview: Participants can expect to improve theirunderstanding of dental sleep medicine in specialized areasof expertise. Clinically-oriented topics will improve theparticipant’s understanding of advanced concepts and improvetheir ability to critically evaluate the current literature andindustry supported claims. Selected topics will be presentedin depth, allowing the practitioner to improve their skill inunderstanding and/or treating complex cases.Topics Include:Surgical Presentation, 8:00am – 10:00am: MMA and PediatricOSA Surgery, Adult Upper Airway Surgery and SurgicalWeight Loss and OSAPediatric Presentation, 10:15am – 12:30pm: Pediatric Sleep andBehavior, Pediatric Sleep Disorders: Prevention and Treatmentand Pediatric Sleep Disorders: Orthodontic and ApplianceTreatmentTarget Audience: AdvancedSpeakers: Barbara Fisher, PhD; Eliot Katz, MD; Kasey Li,DDS, MD; Benjamin Pliska, DDS; R. Bruce Templeton, DMD;and Edward Weaver, MD02: Comprehensive Review ofDental Sleep MedicineTicketed Event8:00am – 12:30pmRoom: Republic BallroomOverview: This educational track is designed for those newer todental sleep medicine. A review of sleep medicine will quicklyimprove the participant’s knowledge base in sleep and whatcan go wrong. Our expert faculty will then take the participantthrough the basics of treating sleep apnea with oral appliances,including the patient examination and appliance selection, aswell as titration considerations and complications management.Target Audience: Dentists relatively new to the field of dentalsleep medicineSpeakers: Kelly Carden, MD, FAASM; B. Gail Demko, DMD,Diplomate, ABDSM; James Metz, DDS, Diplomate; and ToddMorgan, DMD, ABDSM03: Dental Sleep Medicine: Practice Buildingand Practice ManagementFrom Both Sides of the AtlanticTicketed Event8:00am – 12:30pmRoom: Constitution AOverview: This session will provide office staff with a basicunderstanding of billing issues, customer service and referrals.Topics geared towards auxiliary and office staff; limitedregistration will ensure lots of networking and small breakoutsfor question and answers.Target Audience: Clinicians, auxiliary and office staffSpeakers: Jan Palmer; Susanne Schwarting, DDS, Diplomate,ABDSM; and Lydia Sosenko, DDS, Diplomate. ABDSM04: Preparing for the ABDSMDiplomate ExamTicketed Event8:00am – 12:30pmRoom: Constitution BOverview: Learn about the ABDSM certification process. Receivetips from recent Diplomates who have passed the exam in the past2 years. This is not a board review course, but an “I wish I knewthat before I started!” course. Limited registration will ensure lotsof networking and small breakouts for question and answers.Target Audience: Dentists interested in taking the ABDSMCertification examSpeakers: Leila Chahine, DMD, Diplomate, ABDSM; TimothyChrapkiewicz, DDS, Diplomate, ABDSM; James Hogg, DDS,Diplomate, ABDSM; and John Tucker, DMD, Diplomate, ABDSMWe Want Your Feedback | Visit www.aadsm.org/evaluations13

GENERAL SESSIONS Thursday, June 7, 2012EXHIBIT HALL OPENRoom: Back Bay Ballroom7:00am – 5:30pmLunch on Your Own12:30pm – 1:30pmMEET THE PROFESSORSTicketed Events12:30pm – 1:30pmDuring these small-group sessions an expert in dental sleepmedicine will lead an informal discussion on a single topic.01: Olivier Vanderveken, MD, PhDRoom: Exeter Room02: Barbara Fisher, PhD, CBSMRoom: Dalton Room03: B. Gail Demko, DMD, Diplomate,ABDSMRoom: Hampton ABINTRODUCTION, AWARDS ANDKEYNOTE ADDRESS1:30pm – 2:15pmRoom: Grand BallroomSheri Katz, DDS, AADSM PresidentLeslie Dort, DDS, Chair, AADSM Annual Meeting CommitteeFernanda Almeida, DDS, PhD, Chair, AADSM ResearchCommitteeCLINICAL RESEARCH AWARDSOral Appliance Treatment for Pediatric OrthodonticPatients With or Without Sleep ProblemsHui Chen, DMD, MSc, PhDTarget Protrusive Position from MandibularProtrusion Titration: Is It a Good Estimate ofAdequate Protrusion? Does It Correlate with RDI orBMI?Shouresh Charkhandeh, DDS, BMedScMonitoring Adherence to Oral MandibularAdvancement Device TreatmentEric Abrams, DMDGRADUATE STUDENT RESEARCH AWARDSSleep Bruxism-related Tooth Wear as a ClinicalMarker for Pediatric Sleep Disordered BreathingNischal Singh, BDSC, MSDevelopment, Implementation and Evaluation of aClinical Pathway in a Multidisciplinary Dental SleepMedicine ClinicDeirdre Ten BergeThe Dose Dependent Effects of Three NightsIncremental Mandibular Advancement Splint Therapyon Sleep Disordered BreathingJoachim Ngiam, BDS, MSD01: From CPAP to Oral ApplianceTherapy: Lessons of the Past and Perspectivesfor the Future2:15pm – 3:15pmRoom: Grand BallroomSpeaker: Bernard Fleury, MDTarget Audience: DentistsObjectives:1. Describe the main consequences of obstructive sleep apnea(OSA);2. Review the evidence describing the effectiveness of CPAPand oral appliance therapy on the consequences of OSA;and3. Identify the still lacking evidence describing theeffectiveness of oral appliance therapy on the consequencesof OSA.Refreshment Break In Exhibit Hall3:15pm – 3:30pm14 We Want Your Feedback | Visit www.aadsm.org/evaluations

GENERAL SESSIONS Thursday, June 7, 201201: Sleep Tests Part 1: PSG and PortableMonitorsRoom: Grand Ballroom3:30pm – 5:30pmSpeakers: Richard Berry, MD and Christopher Lettieri, MDOverview: This presentation will highlight the need for sleeptesting to assess the therapeutic response of oral appliancetherapy for sleep disordered breathing and explore the potentialroles of portable monitoring as an alternative to in-labpolysomnography.Target Audience: Dentists practicing sleep medicine/sleepdentistryObjectives:1. Discuss the role of sleep dentistry in the evaluation andmanagement of sleep disordered breathing;2. Gain familiarization with diagnostic and oral appliancetitration polysomnographic studies; and3. Explore the role of portable sleep testing in bothestablishing the diagnosis of OSA and confirming thetherapeutic response of oral appliances.AADSM CONGRATULATES 2011DIPLOMATES OF THE ABDSMDiplomate status in the ABDSM is a uniquehonor that recognizes special competencyin dental sleep medicine and significantcontributions to the field. The AADSMis pleased to welcome the following newABDSM Diplomates:• Fernanda Almeida, DDS, Ms, PhD, Diplomate,ABDSM• Timothy Chrapkiewicz, DDS, Diplomate, ABDSM• Leopoldo Correa, BDS, Diplomate, ABDSM• Richard Fischer, DDS, Diplomate, ABDSM• Phillip Hall, DDS, Diplomate, ABDSM• Michael Irwin, DMD, Diplomate, ABDSM• Steven Lamberg, DDS, Diplomate, ABDSM• Jennifer Langner, DDS, Diplomate, ABDSM• Charles Lockhart, DDS, Diplomate, ABDSM• Ajit Pillai, DMD, Diplomate, ABDSM• Angela Planer Venegoni, DDS, Diplomate, ABDSM• Kevin Postol, DDS, Diplomate, ABDSM• Norman Saager, DMD, Diplomate, ABDSM• B. Kent Smith, DDS, Diplomate, ABDSM• David Varland, DDS, Diplomate, ABDSMINDUSTRY-SUPPORTEDEVENTS:NIERMAN PRACTICE MANAGEMENTSuccessful Implementation of Dental Sleep MedicineThursday, June 7, 2012 | 6:00pm – 9:00pmRoom: Constitution BallroomPRESENTERS: Rose Nierman, Dr. John Tucker, and Dr.Mark Van DykeOVERVIEW: Diagnostic report writing is used to buildservices such as TMD and Dental Sleep Medicine as wellas the demonstration of tools, report writing and dental tomedical cross coding. As dentistry becomes more complexand patients present with complicated conditions, dentistryand medicine combine for successful outcomes. Learnhow your office can be reimbursed for medically codedtreatments and generate diagnostic reports and letters tobuild special services in your practice.Please contact Nierman Practice Management directly formore information and to register. Space is limited and preregistrationis strongly encouraged.Nierman Practice ManagementPhone: 800-879-6468Email: office@dentalwriter.comRESMEDIntroducing ResMed’s Narval CC MRDThursday, June 7, 2012 | 6:30pm – 10:00pmRoom: Republic BallroomPRESENTERS: Dr. Roy Dookun, BDS; Dr. Aditi Desai;and Dr. Boris VujovicOVERVIEW: ResMed, a global leader in sleep andrespiratory medicine announces the first and only CAD/CAM MRD at the 2012 AADSM Evening Symposium!Join us for hors d’ oeuvres and drinks and experienceNarval CC through hands-on demonstration. Hear frominternational leaders about their experiences with thedevice. Be the first to see why leaders in the industry preferNarval CC. Kick off the AADSM at the official Narval CCU.S. release party, an event you do not want to miss!Note: Continuing Education Credit may also be availableby attending industry supported events. These creditsare made available by the event organizer and are notprocessed by the AADSM. Please contact NiermanPractice Management or ResMed for more information.We Want Your Feedback | Visit www.aadsm.org/evaluations15

GENERAL SESSIONS Friday, June 8, 2012First Time Attendee Breakfast7:00am – 8:00amRoom: Constitution ABThe AADSM Board of Directors will host a breakfast forall first-time attendees at the 21st Annual Meeting. Thebreakfast will provide an opportunity for all first timeattendees to network with each other as well as gain someinsight into the dental sleep medicine profession. All firsttimeattendees will receive a ticket with their registrationmaterials, which will be required to gain entrance to thebreakfast.Exhibit Hall Open7:00am – 5:30pmRoom: Back Bay Ballroom02: A Year in Review8:00am – 9:00amRoom: Grand BallroomSpeaker: Marie Marklund, DDS, PhDOverview: Dr. Marklund will review the literature relevant todental sleep medicine published in the last twelve months.Target Audience: Dentists interested in dental sleep medicineObjectives:1. Summarize the peer-reviewed publications of the past yearfocused on dental sleep medicine and other topics pertinentto this field; and2. Comment on the new results in relation to existingknowledge in dental sleep medicine.01: OSA: Hypoxia Effects on the Brain9:00am – 10:00amRoom: Grand BallroomSpeaker: Sigrid Veasey, MDTarget Audience: DentistsObjectives:1. Identify effects of intermittent hypoxia on the brain;2. Appraise neurological effects of OSA; and3. Predict effects of OSA on cognition.02: Bite RegistrationRoom: Republic Ballroom9:00am – 10:00amChair: B. Gail Demko, DMD, Diplomate, ABDSMInteractive session with attendees and presenters reviewingmultiple gauges and their various uses.Refreshment Break in Exhibit Hall10:00am – 10:30amPoster Viewing10:00am – 10:30amAll posters are available for viewing in the Grand Ballroomthroughout the AADSM annual meeting. Presenters ofthe posters listed below are available for questions andcomments from 10:00am – 10:30am on Friday, June 8, 2012.POSTER #001TARGET PROTRUSIVE POSITION FROM MANDIBULARPROTRUSION TITRATION: IS IT A GOOD ESTIMATE OFADEQUATE PROTRUSION? DOES IT CORRELATE WITH RDIOR BMI?Charkhandeh S, Topor ZL, Grosse JC, Santosham P,Breuhlmann S, Remmers JEPOSTER #003ORAL APPLIANCES FOR SEVERE OBSTRUCTIVE SLEEPAPNEA: A RETROSPECTIVE ANALYSISCorrea L, Hsu R Lu C, Finkelman MPOSTER #005MONITORING MANDIBULAR ADVANCEMENT APPLIANCES:10 MOST COMMON PROBLEMSSmith, RKPOSTER #007VARIABILITY IN NOCTURNAL RESPIRATORY MEASURESATTRIBUTED TO VERTICAL DIMENSION OF OCCLUSIONMorgan T, Pearcy S, Scarfeo D, Levendowsk DPOSTER #009SIGNS AND SYMPTOMS OF SLEEP DISORDEREDBREATHING (SDB) IN PATIENTS WITH NOCTURNALBRUXISM (NB)Prehn RS, Simmons JHPOSTER #011ORAL APPLIANCE TREATMENT OF OBSTRUCTIVE SLEEPAPNEA: PROGRESSION OF LONG-TERM SIDE EFFECTSPliska BT, Nam H, Chen H, Lowe AA, Almeida FRPOSTER #013MAINTENANCE OF THE PHARYNGEAL AIRWAY DURINGNASAL BREATHING IN DENTURE WEARERSAUTHORS AND INSTITUTIONSYagi K, Azuma T, Nakai R, Almeida FR, Lowe AA, Maeda Y16 We Want Your Feedback | Visit www.aadsm.org/evaluations

GENERAL SESSIONS Friday, June 8, 2012POSTER #015SLEEP BRUXISM-RELATED TOOTH WEAR AS A CLINICALMARKER FOR PEDIATRIC SLEEP- DISORDEREDBREATHINGSingh NPOSTER #017A RANDOMISED SINGLE BLINDED CROSS-OVERCONTROLLED TRIAL STUDY OF TWO OCCLUSAL SPLINTSFOR SLEEP BRUXISM TREATMENT IN THAI SUBJECTSChalidapongse PPOSTER #019CLINICAL MANAGEMENT OF SLEEP BRUXISM IN A CHILD:A CASE REPORTAlfaya TA, Uemoto L, Gouvêa CVD, Bortoletto CC, Motta LJ,Giannasi LC, de Oliveira LVF, Bussadori SKPOSTER #021MONITORING ADHERENCE TO ORAL MANDIBULARADVANCEMENT DEVICE TREATMENTAbrams E, Bogen DK, Kuna ST03: Dental and TMJ Side-Effects of OralAppliances10:30am – 11:30amRoom: Grand BallroomSpeaker: Fernanda Almeida, DDS, PhD, Diplomate, ABDSMOverview: Dr. Almeida will review side-effects related to oralappliance therapy and describe progressive dangers over longtermtherapy.Target Audience: Dentists, researchers and sleep medicinespecialistsObjectives:1. Review current literature on oral appliance side-effects;2. Define possible TMJ side-effects related to oral appliancetherapy;3. Discuss long-term changes and if side-effects ever stop; and4. Analyze potential therapies for oral appliance side-effects.02: Emerging Treatments for OSA11:30am – 12:30pmRoom: Grand BallroomSpeakers: T. Doug Bradley, MD; and Robert Owens, MDOverview: Dr. Bradley will cover, “Overnight Rostral FluidDisplacement and Compression Stockings,” and Dr. Owenswill cover, “Nasal Valves for OSA,” which will discuss hownasal expiratory valves have recently been shown to treat OSAin a subset of patients. The presentation will review possiblemechanisms of action and their role in clinical practice.Target Audience: DentistsObjectives:1. Discuss the potential mechanisms of action by whichcompression stockings and nasal valves treat OSA;2. Identify patients who might benefit from the use ofcompression stockings and nasal valves; and3. Explain how to incorporate compression stockings andnasal valves into a treatment algorithm for OSA.03: Dental Sleep Medicine FacilityAccreditation: Tips for an Efficient andEffective Accreditation Process11:30am – 12:30pmRoom: Republic BallroomChair: Steven Scherr, DDS, Diplomate, ABDSM; and PatriciaBraga, DDSThis session with review the steps for a successful accreditationprocess.Lunch Break on Your Own12:30pm – 1:30pmMEET THE PROFESSORSTicketed Events12:30pm – 1:30pmDuring this small-group session an expert in dental sleepmedicine will lead an informal discussion on a single topic.04: Nancy Addy, DDS, Diplomate, ABDSMRoom: Exeter Room05: Lydia Sosenko, DDS, Diplomate, ABDSMRoom: Dalton Room06: R. Bruce Templeton, DMDRoom: Hampton ABABDSM Informational Session12:30pm – 1:00pmRoom: Republic BallroomLearn about the ABDSM certificationprocess. Board members will be available toanswer questions.We Want Your Feedback | Visit www.aadsm.org/evaluations17

GENERAL SESSIONS Friday, June 8, 201204: Adolescent Sleep–What is Normal / Whatis Not?1:30pm – 2:30pmRoom: Grand BallroomSpeaker: Gila Lindsley, PhD, FAASMOverview: This talk will focus on normal and not-normaladolescent sleep, paying particular attention to sleepabnormalities which can secondarily lead to respiratorydisturbances during the sleep period.Target Audience: DentistsObjectives:1. Describe normal adolescent sleep patterns;2. Evaluate normal age-related changes in sleep; and3. Define common sleep abnormalities in adolescents.03: Pediatric Sleep2:30pm – 4:00pmRoom: Republic BallroomSpeakers: Eliot Katz, MD; and Alan Lowe, DMD, PhD,Diplomate, ABDSMOverview: Dr. Katz will present, “Who to Refer, When toRefer and Where to Refer To,” and Dr. Lowe will present,“Orthodontics in Pediatric OSA,” which will discuss how oralappliances are an effective therapeutic tool for sleep disorderedbreathing in children with specific craniofacial types.Target Audience: Dentists and physiciansObjectives:1. Review the basic mechanisms of mandibular growth;2. Describe the interrelationships between sleep disorderedbreathing, airway size and mandibular posture in growingchildren; and3. Differentiate among sleep disordered breathing in childrenand explain which may be most beneficially treated with anoral appliance.01: Oral Abstract Presentations2:30pm – 4:00pmRoom: Grand BallroomSix selected research presentations of clinical significance willbe presented and discussed.The authors of the following six abstracts will presenttheir research during this session. Authors selected for oralpresentations are allotted a 10-minute time period to presenttheir abstract, followed by a 5-minute time period for questionsand answers. The three-digit poster ID number corresponds tothe abstract listing on page 29.2:30pm - 2:45pmPOSTER #012ORAL APPLIANCE TREATMENT FOR PEDIATRICORTHODONTIC PATIENTS WITH OR WITHOUT SLEEPPROBLEMSChen H, Yagi K, Almeida FR, Pliska BT, Lowe AA2:45pm - 3:00pmPOSTER #001TARGET PROTRUSIVE POSITION FROM MANDIBULARPROTRUSION TITRATION: IS IT A GOOD ESTIMATE OFADEQUATE PROTRUSION? DOES IT CORRELATE WITH RDIOR BMI?Charkhandeh S, Topor ZL, Grosse JC, Santosham P,Breuhlmann S, and Remmers JE3:00pm - 3:15pmPOSTER #021MONITORING ADHERENCE TO ORAL MANDIBULARADVANCEMENT DEVICE TREATMENTAbrams E, Bogen DK, Kuna ST3:15pm - 3:30pmPOSTER #015SLEEP BRUXISM-RELATED TOOTH WEAR AS A CLINICALMARKER FOR PEDIATRIC SLEEP- DISORDEREDBREATHINGSingh N3:30pm - 3:45pmPOSTER #010DEVELOPMENT, IMPLEMENTATION AND EVALUATION OFA CLINICAL PATHWAY IN A MULTIDISCIPLINARY DENTALSLEEP MEDICINE CLINICTen Berge DM, Braem MJ, Altenburg A, Vanhaecht K, Van deHeyning PH, Vanderveken OM3:45pm - 4:00pmPOSTER #002THE DOSE DEPENDENT EFFECTS OF THREE NIGHTSINCREMENTAL MANDIBULAR ADVANCEMENT SPLINTTHERAPY ON SLEEP DISORDERED BREATHINGNgiam J, Norman M, Sullivan CRefreshment Break in Exhibit Hall4:00pm – 4:30pm18 We Want Your Feedback | Visit www.aadsm.org/evaluations

GENERAL SESSIONS Friday, June 8, 2012Poster Viewing4:00pm – 4:30pmAll posters are available for viewing in the Grand Ballroomthroughout the AADSM Annual Meeting. Presenters ofthe posters listed below are available for questions andcomments from 4:00pm – 4:30pm on Friday, June 8, 2012.POSTER #002THE DOSE DEPENDENT EFFECTS OF THREE NIGHTSINCREMENTAL MANDIBULAR ADVANCEMENT SPLINTTHERAPY ON SLEEP DISORDERED BREATHINGNgiam J, Norman M, Sullivan CPOSTER #004CASE STUDY OF THE APNEA/HYPOPNEA CHANGESEFFECTED BY A CUSTOM MADE LOWER ARCH DENTALDEVICE IN CO-THERAPY WITH AUTO-TITRATING C.P.A.P.Alvarez RM, Alvarez JS, Abramowitz JMPOSTER #006ASSOCIATION BETWEEN TEMPOROMANDIBULARDISORDERS SYMPTOMS AND SEVERITY OF OBSTRUCTIVESLEEP APNEACorrea LP, Timmeny M, D’Ambrosio C, Finkelman MPOSTER #008VALIDATION OF IMPORTANT SIGNS AND SYMPTOMS OFSLEEP DISORDERED BREATHING (SDB) IN PATIENTS WITHTEMPOROMANDIBULAR JOINT DISEASE (TMD)Prehn RS, Simmons JH, Gray MPOSTER #010DEVELOPMENT, IMPLEMENTATION AND EVALUATION OFA CLINICAL PATHWAY IN A MULTIDISCIPLINARY DENTALSLEEP MEDICINE CLINICTen Berge DM, Braem MJ, Altenburg A, Vanhaecht K, Van deHeyning PH, Vanderveken OMPOSTER #016TITRATION OF A MANDIBULAR ADVANCEMENT DEVICE INPATIENTS WITH OBSTRUCTIVE SLEEP APNEAAarab G, Dieltjens M, Wouters K, Van de Heyning PH,Vanderveken OM, Braem MJPOSTER #018A NOVEL THERAPY APPROACH FOR SLEEP BRUXISM INCHILD WITH CEREBRAL PALSY - LONG TERM FOLLOW-UPGiannasi LC, Batista SRF, Hardt CT, Matsui MY, Gomes CP,Amorin JBN, Oliveira CS, Oliveira LVF, Gomes MFPOSTER #020EFFECTIVENESS OF ORAL APPLIANCES IN THETREATMENT OF OBSTRUCTIVE SLEEP APNEAFirestone AR, Jones E, Delli-Gatti R, Beck FM, Magalang U04: Compliance Monitoring in Oral ApplianceTherapy4:30pm – 5:30pmRoom: Grand BallroomSpeaker: Olivier Vanderveken, MD, PhDOverview: Dr. Vanderveken will review the proper methods forcompliance monitoring as well as review the latest research oncompliance.Target Audience: DentistsObjectives:1. Deduce the importance of compliance monitoring of OAT;2. Describe methods for compliance monitoring of OAT; and3. Relate current research results for compliance monitoringof OAT.POSTER #012ORAL APPLIANCE TREATMENT FOR PEDIATRICORTHODONTIC PATIENTS WITH OR WITHOUT SLEEPPROBLEMSChen H, Yagi K, Almeida FR, Pliska BT, Lowe AAPOSTER #014THE REGULATION OF BREATHING ROUTE ANDSWALLOWING DURING SLEEP IN PATIENTS WITH SLEEPDISORDERED BREATHINGYagi K, Almeida FR, Chen H, Pliska B, Ayas NT, Fleetham JA,Lowe AAWe Want Your Feedback | Visit www.aadsm.org/evaluations19

GENERAL SESSIONS Friday, June 8, 201201: Practice Building: Communication withthe Sleep Physician4:30pm – 5:30pmRoom: Republic BallroomSpeakers: Kelly Carden, MD; and B. Gail Demko, DMD,Diplomate, ABDSMOverview: This presentation will review effectivecommunication methods to improve your working relationshipswith sleep medicine physicians.Target Audience: Dentists and physiciansObjectives:1. Determine the typical communication channels with yourphysician colleagues;2. Evaluate the proper documentation to facilitatecommunication with physicians; and3. Gain familiarization about the expectations of sleepmedicine physicians.President’sRECEPTIONRoom: Constitution Ballroom6:30pm – 8:00pmThe AADSM Board of Directorsinvites all meeting attendeesto the President’s Reception.The President’s Reception takesplace on Friday, June 8, 2012from 6:30pm - 8:00pm in theConstitution Ballroom at theSheraton Boston HotelThe President’s Reception is asocial celebration featuring horsd’oeuvres, a full-service cash bar,live music and more!AADSM General Membership &Business MeetingRoom: Grand Ballroom5:30pm – 6:00pmThe AADSM Board of Directors invites allattendees to come and learn about the recentactivities and initiatives of the AADSM. TheAADSM Secretary/Treasurer will discuss thefinancial state of the Academy. New membersof the AADSM Board of Directors will beintroduced.20 We Want Your Feedback | Visit www.aadsm.org/evaluations

GENERAL SESSIONS Saturday, June 9, 2012EXHIBIT HALL OPEN7:00am – 3:45pmRoom: Back Bay Ballroom04: Sleep Testing Part 2: ConfoundingConditions “Ambulatory Testing and PSG”8:00am – 9:00amRoom: Grand BallroomSpeaker: Patrick Hanly, MDOverview: This presentation will review the impact of coexistingmedical disorders on diagnostic sleep testing in patientswith sleep apnea.Target Audience: Dentists with an interest in sleep diagnostictestingObjectives:1. Recognize airflow and oximetry profiles which reflectimportant coexisting medical disorders;2. Evaluate the underlying physological mechanismsresponsible for these charges; and3. Describe the therapeutic implications of these findings.05: The Human Circadian Timing System9:00am – 10:00amRoom: Grand BallroomSpeaker: Phyllis Zee, MD, PhDTarget Audience: DentistsObjectives:1. Describe the human circadian timing system;2. Interpret common assessments of human circadianrhythms; and3. Assess circadian rhythm sleep disorders.Refreshment Break in Exhibit Hall10:00am – 10:30am05: Appliance Selection – What Do We KnowToday?10:30am – 12:30pmRoom: Grand BallroomSpeaker: Fernanda Almeida, DDS, PhD, Diplomate, ABDSMOverview: Dr. Almeida will discuss oral appliances design andimpact on treatment outcome.Target Audience: Dentists, researchers and sleep medicinespecialistsObjectives:1. Describe the main differences in appliance designs;2. Review the literature on the impact of mandibularprotrusion and vertical opening; and3. Discuss treatment outcomes related to appliance selection.Lunch Break on Your Own12:30pm – 1:30pmMEET THE PROFESSORSTicketed Events12:30pm – 1:30pmDuring these small-group sessions an expert in dental sleepmedicine will lead an informal discussion on a single topic.Advanced registration is strongly encouraged as seating islimited and sold on a first-come, first-served basis. Lunchis provided at this session. Meals are pre-selected withstandard dietary needs in mind and cannot be substituted toaccommodate special needs.07: Nancy Addy, DDS, Diplomate, ABDSMRoom: Exeter Room08: Alan Lowe, DMD, PhD, Diplomate,ABDSMRoom: Dalton Room09: Marie Marklund, DDS, PhDRoom: Hampton AB06: Stroke and Cardiovascular Consequencesof OSA1:30pm – 2:30pmRoom: Grand BallroomSpeaker: Douglas Bradley, MDOverview: OSA has adverse mechanical, autonomic andinflammatory effects on the cardiovascular system that can leadto development of cardiovascular diseases and that, to someextent, may be amenable to therapy of OSA.Target Audience: DentistsObjectives:1. Describe cardiovascular effects of OSA;2. Identify causes of stroke related to OSA; and3. Discuss mortality and morbidity data of OSA.We Want Your Feedback | Visit www.aadsm.org/evaluations21

GENERAL SESSIONS Saturday, June 9, 201206: Geriatric Sleep2:30pm – 4:00pmRoom: Grand BallroomSpeakers: Sonia Ancoli-Israel, MD; and Susanne Schwarting,DDS, Diplomate, ABDSMOverview: Dr. Ancoli-Israel will cover, “Sleep in the OlderAdult” which will explain how and why the ability to sleepdecreases with age. Dr. Schwarting will cover, “DentalAppliance Treatment in the Geriatric Population.”Target Audience: Any dentist, orthodontist or trainee workingwith older patientsObjectives:1. Examine normal changes in sleep with aging;2. Analyze the common sleep disorders in adults;3. Identify the difference between change in need of sleep andchange in ability to sleep in older adults;4. Evaluate limits of dental appliance treatment due to a lackof adequate dentition;5. Review patient cases as examples; and6. Learn how to broaden your treatment armamentarium tohelp geriatric OSA patients to breathe.07: Hypoglossal Nerve Stimulation forOSA – The State of the Art2:30pm – 3:30pmRoom: Republic BallroomSpeaker: Michael Decker, PhD, RRTOverview: This presentation will review the evolution andtherapeutic efficacy of hypoglossal nerve stimulation for OSA.Target Audience: Clinicians and allied health care providersinterested in the potential role of neurostimulation as atherapeutic intervention for obstructive sleep apnea.Objectives:1. Review the evolution of hypoglossal nerve stimulationfor OSA from the intitial proof-of-concept studies to thecurrent clinical trials;2. Describe functional characteristics of currently available,implantable, hypoglossal nerve stimulators; and3. Analyze inclusion/exclusion criteria to aid in selectingpotential patients who may be candidates for hypoglossalnerve stimulation as a treatment for OSA.08: Complicating Condition and OSA4:00pm - 5:00pmRoom: Grand BallroomSpeakers: William Orr, PhD; and Thomas Roth, PhDOverview: Dr. Orr’s lecture, “Sleep Apnea andGastroesophageal Reflux: Respiratory and OralComplications,” will review the pathophysiology of sleeprelated gastroesophageal reflux and the respiratory and oralcomplications of the proximal migration of acidic and nonacidicreflux. Dr. Roth’s lecture, “Insomnia and OSA” willdiscuss that even though OSA is thought of presenting withsleepiness/fatigue and snoring, there are significant OSAsubpopulations presenting with insomnia.Target Audience: Dentists practicing sleep medicineObjectives:1. Review the pathogensis of sleep related gastroesophagealreflux;2. Explain the proximal migration of acidic and non-acidicreflux and the upper airway and oral complications of acidand non-acidic reflux;3. Discuss the latest methodologies for measuringgastroesphoageal reflux during sleep;4. Examine the pathophysiology of sleep relatedgastroesophageal reflux in OSA;5. Describe the prevalence of OSA patients presentingwith insomnia, as well as the prevalence of OSA amonginsomnia patients;6. Identify the risk factors for OSA among those reportinginsomnia;7. Examine the relation of insomnia therapies and OSAtreatments; and8. Analyze the effect of OSA treatments on sleep.05: Medicare Issues for Dental Sleep Medicine4:00pm – 5:00pmRoom: Republic BallroomChair: Sheri Katz, DDS, Diplomate, ABDSMSpeaker: Michael Hanna, MDTarget Audience: IntermediateObjectives:1. Describe the Medicare enrollment process for DMEsuppliers;2. Explain Medicare’s documentation requirements for DMEsuppliers; and3. Identify Medicare’s repair and replacement guidelines forDME supplies.22 We Want Your Feedback | Visit www.aadsm.org/evaluations

EXHIBIT HALLBooth Company Name44 Airway Management, Inc.30 Airway Metrics LLC20 Apnea Sciences Corporation33 Appliance Therapy Group23 The Barnes Group21 Begin Healing, Inc.8 BRAEBON Home Apnea Testing37 Cadwell Therapeutics Inc.5 CleveMed17 Dental Marketers LLC19 Dental Prosthetic Services36 Dental Services Group38 Dental Sleep Solutions, LLC16 Distar18 Dormoco – Respident40 DynaFlex25 Frantz Design Inc. – Myerson Tooth Co.41 Gergen’s Ortho and Sleep Lab12 Glidewell LaboratoryBooth Company Name6 GoGo Billing – Medical Billing for Dentists22 Great Lakes Orthodontics Ltd.4 Henry Schein Dental26 Itamar Medical7 John’s Dental Laboratory3 Modern Dental Laboratory USA1 Nierman Practice Management24 Oasys Oral/Nasal Airway Systems39 pm-Assist ® Sleep Scoring & Interpretation Service43 SANOSTEC Corp.35 Sleep Apnea MD42 Sleep Optima13 Snoring Isn’t Sexy, LLC28 SomnoMed11 Springstone Patient Financing31 Strong Dental10 TMD Technologies15 TMNDx Sleep Software14 Watermark MedicalENTRANCEWe Want Your Feedback | Visit www.aadsm.org/evaluations23

EXHIBITOR LISTINGBOOTH NUMBER: 5CleveMedCleveland, OHwww.clevemed.comCleveMed is expanding the reach of your sleep services todayand tomorrow by offering innovative technologies for emergingsleep markets. From HST to PSG our devices on portability andease of use.BOOTH NUMBER: 17Dental Marketers LLCWoodbridge, ON, Canada877-265-9069www.dentalmarketers.comAre you looking for more quality patients, growth andprosperity? Take the guesswork out of your marketing. Have theconfidence in knowing that Dental Marketers has over 20 yearsof experience marketing exclusively for dentists! Print, websites,networking campaigns and much more!BOOTH NUMBER: 19Dental Prosthetic ServicesCedar Rapids, IA800-332-3341www.dpsdental.comDental Prosthetic Services has been equipping dentists tosuccessfully practice dental sleep medicine for more thana decade. DPS offers a diverse selection of FDA-clearedappliances, highly skilled lab technicians, administrativeassistance in filing medical insurance claims, and help withdeveloping your dental sleep medicine practice.BOOTH NUMBER: 36Dental Services GroupGreensburg, PAwww.dentalservices.netDental Services Group is a network of 25 full-servicedental laboratories offering premier oral sleep appliances –SomnoDent, TAP, Adjustable PM Positioner, and EMA. Withover 20 years of experience in dental sleep medicine, DSGoffers you exceptional practice support, unequalled technicalskills, educational programs and sleep practice developmenttools.BOOTH NUMBER: 38Dental Sleep Solutions, LLCHolmes Beach, FL877-95-SNOREwww.dentalsleepsolutions.comDental Sleep Solutions exists to provide member dentists withtraining, support, and turn-key systems to maximize patientacceptance of oral appliance therapy and practice efficiency.Our extensive training and clinically-proven systems enable youto be the “go to” dental sleep expert in your community. Joinour team today!BOOTH NUMBER: 16DistarAlbuquerque, NM800-477-6673www.distar.comIntroducing Dr. Tom Meade’s new appliance: The TheraSom-Cast. The TheraSom-Cast, distributed by Distar, is the latest inoral appliance therapy for treating OSA allowing more space forthe tongue, adjustable, and only minimal protrusion required.With a five year warranty this could be the last appliance yourpatient will ever need.BOOTH NUMBER: 18Dormoco - RespidentNijlen, Belgiumwww.respident.comDormoco Ltd develops titrators and dental arch anchor systemsfor oral appliances that are applied in the field of Dental SleepMedicine. RespiDent®, Dormoco’s leading brand, distributesthe patented Butterfly MRA® and the SleepStar MRA® (Patentpending). The patented dental arch anchor system is the DentalClip®. In 2011, Dormoco introduced Air Aid Sleep®, the firstvalid and reproducible compliance monitoring system designedfor Dental Sleep Medicine. Dormoco products passed severalacademic studies.BOOTH NUMBER: 40DynaFlexSt. Ann, MO800-489-4020www.dynaflex.comDynaFlex has FDA Clearance for 8 different oral devices;two also have Medicare E0486 code verification. This year,DynaFlex will feature the new “Dorsal AirPlus” oral device.The unique modifications to the original finned design Dorsalprovide maximum tongue space for the patient and enhancedairway response. Please stop by the DynaFlex booth.We Want Your Feedback | Visit www.aadsm.org/evaluations25

EXHIBITOR LISTINGBOOTH NUMBER: 25Frantz Design Inc. - The Myerson Tooth Co.Katy, TX800-588-7898www.openairway.comThe EMA Oral Appliance from Myerson increases airwayspace by advancing the mandible using interchangeable straps.FDA cleared for the treatment of snoring and Obstructive SleepApnea, EMA’s patient friendly design offers advantages notfound in other oral appliances.BOOTH NUMBER: 41Gergen’s Ortho and Sleep LabPhoenix, AZ866-437-4361www.gergensortho.comTBDBOOTH NUMBER: 12Glidewell LaboratoriesNewport Beach, CA800-854-7256www.glidewelldental.comGlidewell Laboratories proudly offers four powerfulprescriptions for snoring and/or sleep apnea. Prescribe TAP3 TL, EMA, or Silent Nite sl for the treatment of sleep apneaand snoring. Or order the aveoTSD to aid in the treatment ofsnoring. To learn more, visit our booth, www.glidewelldental.com, or call 800-854-7256.BOOTH NUMBER: 6GoGo Billing - Medical Billing for DentistsGlendale, AZ877-874-4646www.gogobilling.comGoGo Billing is a full service billing company createdexclusively for dentists. They will handle everything from theinitial benefit phone call, pre-certifications, GAP requests tofinal claim submissions and appeals. Don’t let the stress ofmedical billing stop you from treating your patients, just give itto GoGo!BOOTH NUMBER: 22Great Lakes OrthodonticsTonawanda, NY800-828-7626www.greatlakesortho.comGreat Lakes Orthodontics has a variety of proven alternativeoral dental appliances, used for the treatment of chronicsnoring and select cases of obstructive sleep apnea. For over10 years, our featured appliance is the Adjustable KlearwayOral Appliance invented by Dr. Alan Lowe. In addition, wehave the adjustable Herbst Appliance and two single positionedappliances. We also have the capability of networking dentistsand the sleep community for the utmost care for the patient.Stop by and see our selection of screeners!BOOTH NUMBER: 4Henry Schein DentalMelville, NYwww.sleepcomplete.comHenry Schein Sleep Complete is the turnkey program thatdelivers all the education and products necessary for thesuccessful implementation of dental sleep medicine in yourpractice.BOOTH NUMBER: 26Itamar Medical, Inc.Franklin, MAwww.itamar-medical.comWatchPAT: Convenient, portable sleep apnea testing deviceinstalled by the patient in their own home with over 350,000tests worldwide. It replaces a sleep lab all without cumbersomenasal cannulas or belts. Offers greater patient comfort, morenatural sleep, and amazingly low failure rate. Request your freesleep test at the show.BOOTH NUMBER: 7John’s Dental LaboratoryTerre Haute, IN800-457-0504www.johnsdental.comJohn’s Dental is a full service lab which fabricates sleep apneaappliances, along with TMJ splints, full & partial dentures,fixed & removable orthodontic appliance, crown & bridge.26 We Want Your Feedback | Visit www.aadsm.org/evaluations

EXHIBITOR LISTINGBOOTH NUMBER: 3Modern Dental Laboratory USABellevue, WA877-711-8778www.moderndentalUSA.comModern Dental Laboratory USA is the exclusive distributor ofThe Moses device, the only Oral Airway Dilator that has all 3necessary attributes for a successful sleep apnea and snoringdevice: Tongue Management, Mandibular Advancement andPatient Compliance. We are proud to also include the EMA FirstStep and the EMA Custom device in our product suite.BOOTH NUMBER: 1Nierman Practice ManagementTequesta, FL800-879-6468www.dentalwriter.comSince 1988, we have helped dental practices expand into specialservices. DentalWriter Diagnostic Report and Medical Billingsoftware utilizes Online Questionnaires and CustomizableForms to streamline medical billing and referrals. NiermanPractice Management offers the tools and training needed tofeel confident while implementing Dental Sleep Medicine intoyour practice.BOOTH NUMBER: 24Oasys Oral/Nasal Airway SystemsRoseville, CA916-865-4528www.oasyssleep.comThe Dental and ENT, FDA cleared, OASYS Oral / NasalAirway System, builds upon the benefits of MandibularAdvancement, but enhances OSA treatment with patented NasalDilator Buttons, and Tongue Training Buttons, addressingthe nose and throat. The new design offers significantadvancements, including New Locks and a MM markingsystem.BOOTH NUMBER: 39pm-Assist® Sleep Scoring & Interpretation ServicePhiladelphia, PA800-624-3784www.pm-assist.compm-Assist SM allows dentists using home sleep testing devicesto upload raw data that is reviewed by RPSGTs, interpreted byBoard Certified Sleep Physicians, and in as little as 24 hoursreceive a diagnostic report. Our Sleep Physicians medicallylicensed in all 50 states offer a consistent level of servicenationwide.BOOTH NUMBER: 43SANOSTEC Corp.Beverly Farms, MA800-797-0361www.maxairnosecones.comSANOSTEC’s premium nasal airway relief aids, Sinus Conesand Max-Air Nose Cones®, are used with oral appliances totreat and relieve sleep apnea and aid compliance. Patented,latex-free, and hypoallergenic the Cones gently stent nasalairflow, and are backed by published studies showing 2Xefficacy of the Breathe Right® strips.BOOTH NUMBER: 35Sleep Apnea MDBoca Raton, FL888-306-1162www.sleepapneamd.comSleep Apnea MD is a full service, highly trained, marketingcompany that specializes in Sleep Apnea and SnoringMarketing. Sleep Apnea MD only uses proven Internet SearchEngine Optimization techniques. For more information visit ourbooth. We are dedicated to providing doctors, dentists, sleepcenters and suppliers nothing but results!BOOTH NUMBER: 42Sleep OptimaCleveland, OH877-699-9983www.sleepoptima.comImplementing Dental sleep medicine is a complex and seriousundertaking that simply cannot be perfected in a weekendcourse or by simply purchasing software. At Sleep Optimawe tailor our proven techniques to your practice’s currentprotocols. We provide a comprehensive system for a complete,customizable sleep dentistry program.BOOTH NUMBER: 13Snoring Isn’t Sexy, LLCNew York, NY888-203-0488www.snoringisntsexy.comIt’s no secret that searching for doctors begins online. OnlySnoring Isn’t Sexy can help you reach potential patients with thepower of search engines, social networks and traditional media.We track what’s trending and get the buzz. We get you found bythe people who need to find you.We Want Your Feedback | Visit www.aadsm.org/evaluations27

EXHIBITOR LISTINGBOOTH NUMBER: 28SomnoMedFrisco, TX888-447-6673www.somnomed.comSomnoMed provides the oral sleep apnea applianceSomnoDent®, a Class II Medical Device that is FDA clearedand clinically validated to effectively treat OSA. Each custommade SomnoDent® goes through an FDA/ISO compliantmanufacturing and quality control process. Experience thebenefit of treating OSA patients successfully with SomnoDent®.BOOTH NUMBER: 11Springstone Patient FinancingSouthborough, MA800-630-1663www.springstoneplan.comSpecializing in larger cases, Springstone Patient Financing SMoffers plans to $40,000 and fixed rates from 5.99% APR.Practices pay only 7.9% for 12 month no-interest* plans($4,000+). Experience outstanding customer care with a 5 yearperfect record with the Better Business Bureau. Let’s talk! 800-630-1663. *For plan details, visit springstoneplan.com.BOOTH NUMBER: 31Strong DentalDetroit, MI800-339-4452www.strongdental.comStrong Dental is a quality-oriented dental laboratory thatspecializes in the manufacturing and distribution of premium,effective oral appliances across North America. Our signaturesleep appliance line includes The SUAD Device, TheSUAD Elite, The SUAD Ultra Elite (SUE), The TemporarySUAD Appliance (TSA), and the Morning Repositioner.BOOTH NUMBER: 15TMNDx Sleep SoftwareLa Mesa, CA800-423-3270www.tmndx.comCustomized for your practice needs, TMNDx provides astreamlined path to meet the standard of care for a simpleand easy integration of Sleep in the general dental practice.Narrative Report of Findings and the Appointment LinkedMedical Billing provides optimum success in reimbursementand marketing for the future of your practice.BOOTH NUMBER: 14Watermark MedicalBoca Raton, FL877-710-6999www.watermarkmedical.comWatermark Medical targets the physician, dental and sleepclinic markets, selling the ARES Home Sleep Testing solutionfor diagnosing sleep disordered breathing. Our web portalenables practitioners to improve patient care through a turn-keyhome solution that includes comprehensive screening, homesleep testing, treatment recommendations and life-long diseasemanagement.BOOTH NUMBER: 10TMD TechnologiesSnellville, GA800-863-2125www.tmdtechnologies.comA boutique laboratory specializing in TMJ splints/orthotics andsleep appliances. Also, exclusively available is ‘The Airhead’OSA patient demonstration model.28 We Want Your Feedback | Visit www.aadsm.org/evaluations

ABSTRACTSThe posters are available for viewing in the general sessionroom, the Grand Ballroom, on Friday, June 8, 2012. The posternumber listed below corresponds with the poster numberslocated on the top corners of the poster boards. Authors willbe present at their poster boards on Friday, June 8 duringrefreshment breaks to field questions or comments about theirposters.Authors with odd-numbered poster board ID numbers will be attheir posters on Friday, June 8, 2012 from 10:00am – 10:30am.Authors with even-numbers poster board ID numbers will be attheir posters on Friday, June 8, 2012 from 4:00pm – 4:30pm.Please see the schedule on pages 16-17 and 18-19.POSTER #001TARGET PROTRUSIVE POSITION FROMMANDIBULAR PROTRUSION TITRATION: IS IT AGOOD ESTIMATE OF ADEQUATE PROTRUSION?DOES IT CORRELATE WITH RDI OR BMI?Charkhandeh S, Topor ZL, Grosse JC, Santosham P,Breuhlmann S, and Remmers JEUniversity of Calgary, Edmonton Dental Studio Groups, ZephyrSleep TechnologiesIntroduction: We have developed a mandibular protrusiontitration test (MATRx, Zephyr Sleep Technologies) thatis intended to select patients with obstructive sleep apnea(OSA) for oral appliance therapy. In this test, the mandible isprogressively protruded by a remotely controlled mandibularpositioner during polysomnographically (PSG) monitoredsleep. The therapeutic dentist fits the patient with chair-sidecustom fitted trays and determines the range of mandibularmotion which is conveyed to the sleep laboratory. A qualifiedphysician interprets test, predicts therapeutic outcome of oralappliance therapy, and provides the dentist a target therapeuticprotrusive distance required to eliminate sleep apnea. Wereport in a separate presentation (APSS, 2012) the results of aprospective, predictive clinical trial which shows that the testhas excellent positive predictive powerThus, the mandibularprotrusion titration test appears to have predictive accuracy thatis adequate for selecting patients for oral appliance therapy. Thepresent study tests the hypothesis that this target therapeutic,provided by the test, position agrees with the actual position thatprovided therapeutic success.Methods: Patients (n=58) having a broad range of (20.9-30.1) and RDI (10.8-56.3) values underwent mandibularprotrusive titration in a PSG setting. They then received acustom mandibular protruder (SomnoDent, SomnoMed) setat the target position. Both the interpreting physician and thetherapeutic dentist were appropriately blinded . After the test,the dentist was provided the target position determined in thetest for patients predicted to be therapeutic successes or a shamvalue (70% of full protrusion) for those predicted to fail oralappliance therapy. Baseline and therapeutic outcome RDI weredetermined by a home respiratory evaluation during sleep usingvalidated portable monitor (Snoresat, SagaTech), and therapeuticsuccess was defined as a value less than 10 hr-1. Patients whowere not therapeutic successes at target position receivedadditional protrusion of their appliance and were retested in afinal position, after full clinical adjustment.Results: In 30 of the patients, mandibular protrusion satisfiedthe prospectively established criterion for predicting therapeuticsuccess, i.e., AHI≤12hr.-1 during REM sleep in the supineposture. Of these 28 (93%) displayed therapeutic success atthe target protrusive position, which averaged 65.9% of fullprotrusion. The two therapeutic failures became successes afteradditional protrusion (21% and 31%), and the final group meanprotrusive position was 67.8%. We evaluated other variablesthat might predict a therapeutically successful position, andcorrelated RDI and BMI with final, successful protrusiveposition. Neither variable correlated significantly with thetherapeutically successful position (r2 =.0035 and .00006,respectively).Conclusion: In addition to accurately identifying OSA patientswho will be successfully treated with an oral appliance, themandibular protrusion titration test provides a therapeuticallyadequate target position in almost all patients.Supported by a grant from Alberta InnovationPOSTER #002THE DOSE DEPENDENT EFFECTS OF THREENIGHTS INCREMENTAL MANDIBULARADVANCEMENT SPLINT THERAPY ON SLEEPDISORDERED BREATHINGNgiam J, Norman M, Sullivan CUniversity of Sydney, NSW, AustraliaIntroduction: Assessments of the efficacy of mandibularadvancement splints (MAS) have previously demonstrated adose dependent relationship with the apnea hypopnea index(AHI). Snoring, a key symptom of sleep disordered breathing(SDB), is rarely measured and quantified objectively. Theaim of our study was to assess and quantify the efficacy ofMAS treatment on the AHI and snoring following 3 nights ofincremental mandibular advancement with a novel method ofself administered at home evaluation of SDB.Methods: We studied 36 adults (27 male) on sequential nightswith and without a MAS device. The subjects slept the firstnight without the MAS and on each sequential night following,the MAS was advanced to the 70% maximum protrusion (MP),We Want Your Feedback | Visit www.aadsm.org/evaluations29

ABSTRACTS70% MP +1mm and 70% MP +2mm. Recordings were madeusing a portable unobtrusive device that has sensors containedwithin a mattress overlay requiring no attachment to the subject.Apneas, hypopneas, snoring and body movements are recordedin order to generate snoring indices and AHI.Results: MAS treatment significantly reduced the AHI in adose dependent manner from 10.4 ± 8.4, to 7.0 ± 8.7 and 5.3± 8.8 events/hour; (p25% of the night at both the 70%MP+1mm and 70% MP+2mm positions. Several subjects hadsubstantial increases in snoring from baseline.Conclusions: MAS treatment is effective in reducing AHIand snoring but snoring may persist or even increase in asignificant number of patients despite progressive mandibularadvancement. It appears that the dose-dependent decreasein inspiratory snoring is countered, to a degree, by the dosedependent increase in expiratory snoring resulting in a ceilingeffect when total snoring is examined. Objective quantificationof snoring during MAS therapy is thus warranted as thetreatment aims to abolish both apneas and snoring.POSTER #003ORAL APPLIANCES FOR SEVERE OBSTRUCTIVESLEEP APNEA: A RETROSPECTIVE ANALYSISCORREA L, HSU R, LU C, FINKELMAN MTufts University School of Dental Medicine, Boston, MAthat occur during sleep, often resulting in reduction of bloodoxygen saturation and arousals from sleep. Obstructive sleepapnea is a common disease that is largely under-diagnosedand untreated with significant implications for cardiovasculardisease, mortality, and economic impact. There is increasingevidence that oral appliances can be an effective treatment forpatients with obstructive sleep apnea. Oral appliances for thetherapy of obstructive sleep apnea is a non-invasive alternativetherapy for obstructive sleep apnea patients. The currentprofessional guidelines recommend the use of oral appliancesfor mild to moderate obstructive sleep apnea and for severesleep apnea on patients who have failed the use of continuouspositive air pressure machine.Methods: This retrospective chart review was approved byTufts University IRB. A power calculation was conductedusing nQuery Version 7.0. Assuming a mean improvement of10 points, and a standard deviation of 10 points, a sample sizeof n = 13 achieved a power of 91%. Data were obtained fromthe medical records of thirteen subjects eighteen years of ageor older with severe obstructive sleep apnea (AHI ≥ 30) treatedat the Dental Sleep Medicine Clinic, Craniofacial Pain CenterTufts University School of Dental Medicine. Sleep parameterscollected from baseline diagnostic polysomnogram includedpresence of severe obstructive sleep apnea measured by ApneaHypopnea Index (AHI), rapid eye movement sleep stage(REM), and nadir oxygen saturation nSO2. Post treatment sleepparameters were collected using home sleep monitor.Statistics Analysis: The analysis, which was performed usingSPSS version 19.0, included univariate analysis to examine thedata. Continuous variables were examined for non-normality.The paired t-test was used to assess if changes were statisticallysignificant. Level of significance was set at p < 0.05.Results: AHI had a mean decrease of 38.20 (SD =19.04) betweenbaseline and follow-up (p < .001). REM had a mean increaseof 8.97 (SD=9.90) between baseline and follow-up (p = .007).NSO2 had a mean increase of 5.93 (SD=11.00) between baselineand follow-up (p = 0.076).Conclusions: Our study showed statistically significantimprovement for AHI and REM. No statistically significantdifference was observed for nSO2. Current practice parametersrecommend the use of oral appliances on severe sleep apnea onpatients who tried and failed the use of CPAP. Oral appliancesappear to be an alternative to CPAP therapy. Further researchis necessary to determine maxillo-mandibular factors andtreatment protocols associated with favorable treatmentresponse.Introduction: Obstructive Sleep Apnea (OSA) is a conditioncharacterized by repetitive episodes of upper airway obstruction30 We Want Your Feedback | Visit www.aadsm.org/evaluations

ABSTRACTSPOSTER #004CASE STUDY OF THE APNEA/HYPOPNEACHANGES EFFECTED BY A CUSTOM MADELOWER ARCH DENTAL DEVICE IN CO-THERAPYWITH AUTO-TITRATING C.P.A.P.Alvarez RM, Alvarez JS, Abramowitz JMObjective: To determine the effects of a lower arch flexiblecustom dental device (P3®) to reduce Apnea-Hypopnea index inco-therapy with A.P.A.P. (REM STAR Auto System One®).Study Design: Single white male age – 57, height – 5’9”, weight200 lb. ± 3 lb., B.M.I. 39.5, A.P.A.P. compliant 175 nights of thedata without dental device and 175 nights with dental device.Methods: A custom lower dental device was used. It is madewith a flexible vinyl material with minimal vertical dimension.There is special Protuberances/Torus on the lingual flange.These Torus engage the tongue reflex. The stimulation aftereach swallow guides the tongue to a more anterior position.Results: The Apnea/Hypopnea Index was reduced significantly(5.6/hr. to 3.2/hr.). The teeth and the TemporomandibularJoint are protected from the effects of bruxism and clenching.Excellent A.P.A.P. compliance continues without extra P.A.P.pressure.APAP:8/11/2010 - 2/1/2011 (175 days)Days with Device Usage 175 daysDays without Device Usage 0 daysPercent Days with Device Usage 100.0%Cumulative Usage 55 days 11 hrs. 4 mins. 32 secs.Maximum Usage (1 Day) 12 hrs. 24 mins. 36 secs.Average Usage (All Days) 7 hrs. 36 mins. 22 secs.Average Usage (Days Used) 7 hrs. 36 mins. 22 secs.Minimum Usage (1 Day) 2 hrs. 2 mins. 27 secs.Percent of Days with Usage > = 4 Hours 98.3%Percent of Days with Usage < 4 Hours 1.7%Average AHI 5.6Auto CPAP Mean Pressure 8.3 cmH2OAuto CPAP Peak Average Pressure 11.1 cm H2OAverage Device Pressure < = 90% of Time 9.9 cm H2O“CO-THERAPY”:2/2/2011 - 7/26/2011 (175 days)Days with Device Usage 175 daysDays without Device Usage 0 daysPercent Days with Device Usage 100.0%Cumulative Usage 63 days 18 hrs. 44 mins. 47 secs.Maximum Usage (1 Day) 12 hrs. 32 mins. 1 secs.Average Usage (All Days) 8 hrs. 44 mins. 49 secs.Average Usage (Days Used) 8 hrs. 44 mins. 49 secs.Minimum Usage (1 Day) 1 hrs. 46 mins. 1 secs.Percent of Days with Usage >= 4 Hours 97.7%Percent of Days with Usage < 4 Hours 2.3%.Average AHI 3.2Auto CPAP Mean Pressure 8.9 cm H2OAuto CPAP Peak Average Pressure 11.8 cm H2OAverage Device Pressure < = 90% of Time 10.9 cm H2OConclusion: The tongue guidance effect by the Protuberances/Torus on the lingual area of the lower arch custom dental deviceprovides stimulation to the genioglossus muscle and engagesit to a more anterior position. This action creates a dilationof the pharynx subsequently reducing the airway resistancewhich lowered the Apnea/Hypopnea Index significantly morethan A.P.A.P. alone. Co-therapy now can be achieved with acomfortable lower arch dental device that allows for a superiorlip seal.POSTER #005MONITORING MANDIBULAR ADVANCEMENTAPPLIANCES: 10 MOST COMMON PROBLEMSSmith RK, DDSSanta Cruz, CAIntroduction: Custom made adjustable oral appliances,mandibular advancement devices (MAD) have become animportant adjunct treatment for Obstructive Sleep Apnea (OSA).This article is focused on evaluating certain aspects of applianceuse and drawbacks leading to treatment complications.OurAcademy of Dental Sleep Medicine Journal Dialogues Issue2 from 2010 compiled a list of complications and treatmentwith the use of all oral appliance therapy (OAT). I have treatedOSA related symptoms on nearly one thousand patients overthe last 20 years in private practice. Working with several sleeplabs, I have combined the 10 most common complications andoffer how to treat them. This abstract is to encourage furtherdiscussion so this topic will continue being examined.Methods: The first complication is emotions . The patient can’twear appliance, is choking or gasping. Second is retention,the appliance is too loose or tight and there is tooth mobilityor soreness. Third is occulsal changes. The patient’s bitechanges ,only bites on one side, or there is a posterior openbite. There are open contacts or a crown comes off. The fourthcomplication is bad taste or odor. The appliance has a whitechalky buildup. The fifth complication is TemporomandibularJoint ( TMJ) Pain. The jaw shifts to one side, they can’t closeor only bite on one side. The sixth complication is excess salivaor a dry mouth. The seventh complication is continual snoringand appliance seems to have stopped working. The eighthcomplication is long term use and conjunctive therapy with theCPAP. The ninth complication is tissue impingement; the patienthas high cheek bones, tori or osseous hypertrophy. The lastcomplication is the AHI/RDI is worse.We Want Your Feedback | Visit www.aadsm.org/evaluations31

ABSTRACTSResults: Weekly monitoring is used for choking/gasping patients. If patient is claustrophobic or anxious ,recommendation is to try in 30 minute intervals. Adjustmentscan be made to the appliance with a crosscut lab bur andpolished with scotch-brite brush or alcohol tourch. Removeappliance and evaluate for severe bruxism. Adjust applianceto close contacts. Add material to distal molars. Cement theweakest link and recement crown, then continue with recementas this is the weakest link of all crowns.Soak in water, washwith soap and soak in denture cleaner 30-60 minutes once amonth.Discontinue use and be treated with anti-inflammatorymedication and muscle relaxants. Add anterior disclusion ramp,move back at first sign of problems and consider referral tophysical therapy. There is a normal digestive process until thebrain recognizes no calories. A dry airway is expected andwill occur due to increased airflow when appliance is titrated.Continue increasing the adjustment to advance mandible painfree. It is possible to increase vertical dimension. ConsiderUPPP surgery due to increased inflammation and scarring as aresult of chronic snoring. If patient can’t form a proper seal, afull mask is needed.Trim excess material or change appliancedesign. Home sleep study vs. lab study, sleep interpretation.Success in the absence of decreased AHI and RDI, increasedsleep latency, increased sleep efficiency and decreasedmean length of apnea duration and an increased dip score. Iconsider being overall, subjective improvement as to cognitiveawareness.Conclusion: The hope is to accomplish and encourage betterdiscussion to promote this kind of investigation.POSTER #006ASSOCIATION BETWEEN TEMPOROMANDIBULARDISORDERS SYMPTOMS AND SEVERITY OFOBSTRUCTIVE SLEEP APNEACorrea LP 1, Timmeny M 1 , D’Ambrosio C 2 , Finkelman M 11Tufts University School of Dental Sleep Medicine2Tufts Medical Center, Center for Sleep MedicineAim of the study: To evaluate the relationship betweentemporomandibular disorders symptoms (TMDs) and severityof obstructive sleep apnea (OSA).Introduction: OSA is a common disease largely underdiagnosedand untreated characterized by repetitive episodesof upper airway obstruction during sleep with significantcomorbidities including cardiovascular conditions. Longitudinalepidemiological studies have showed that the prevalence of OSAin the United States in middle aged population is 2% and 4%in women and men respectively. Previous studies have shownthat subjects diagnosed with sleep disorders have an increasedpain sensitivity, and exhibit reduced pain thresholds. TMDsymptoms is characterized by pain affecting the masticatorymuscles, TMJ, neck and face areas, TMD affects an estimated12% of the US population. Treatment outcome for TMDcondition may be affected by the presence of sleep disordersspecially OSA. Currently these two conditions are evaluatedand treated separately. If an association between TMDsymptoms and OSA exist, a closer multidisciplinary approachbetween sleep physicians and dentists may be beneficial forpatients suffering these conditions.Methods: Cross sectional study approved by the TuftsUniversity IRB, informed consent to participate in researchwas obtained from eighty four unselected males andfemales eighteen years of age or older attending a certifiedsleep disorders laboratory. A visual analog scale (VAS)containing twelve questions related to TMD symptoms wasanswered by the participants prior to undergoing a full nightpolysomnography (sleep study) for the diagnosis of OSA. Theresults from the sleep study to determine the presence of OSAwere scored and reviewed by a certified polysomnographytechnician and sleep physician.Statistical analysis was performed using SPSS software.Chi-Square was performed to test for an association betweentwelve TMD symptoms and OSA. Ordinal logit model wasperformed for ordering of the TMD categories. Then for OSAa multivariable logistic regression model predicting TMD wasbuilt. Level of significance was set at p < 0.05.Results: 48 male and 36 females age 19 to 79 (mean 49.8)answered the VAS scale. OSA was diagnosed in 66 subjects(78.6%). No statistical significance (p > 0.05) was foundbetween the presence of TMD symptoms and OSA.Conclusions: Despite the presence of TMD symptoms inour group population, there was no statistically significantcorrelation between TMD symptoms and OSA. One limitationwas the number of subjects recruited. A statistical significancewas found between BMI with a cutoff of 25 and OSA.Dentists should use screening questionnaires that include BMImeasurement for sleep disordered breathing. Future researchcould be emphasis on relationship between TMD symptoms,quality of sleep and sleep stages.POSTER #007VARIABILITY IN NOCTURNAL RESPIRATORYMEASURES ATTRIBUTED TO VERTICALDIMENSION OF OCCLUSIONMorgan T 1, Pearcy S 1 , Scarfeo D 2 , Levendowski D 21Scripps Memorial Hospital2Advanced Brain MonitoringIntroduction: The vertical relationship between the upperand lower arch in optimizing oral appliance therapy (OAT) is32 We Want Your Feedback | Visit www.aadsm.org/evaluations

ABSTRACTSnot well understood. Nocturnal measures used to assess OAToutcomes (i.e., conversion of apneas to hypopneas, reduction inthe depth of desaturation for sleep disordered breathing events,and snoring loudness) are influenced by factors includingnight to night variability, supine sleep supine and the vertical/protrusive oral appliance setting. These case studies investigatepatterns that suggest the need for controls so that the influenceof the vertical dimension on OAT can be assessed.Methods: Four males, all diagnosed with obstructive sleepapnea and being treated with custom appliances were studied.Each were fitted with a low and high Apnea Guard ® temporaryappliance (Advanced Brain Monitoring, Carlsbad,CA). Thelow size provides 5.5 mm of anterior and posterior verticaldimension of occlusion (VDO). The high provides 8 mm ofanterior and 6 mm of posterior VDO. Both appliances were setto 70% of maximum protrusion using the inserted appliancesto measure neutral and maximum. Home sleep tests wereperformed first with the low and then the high size using theARESTM Unicorder. The auto-scoring rules were appliedto determine the overall, supine and non-supine apnea index(AI) and apnea hyopopnea index (AHI), percent time snoring> 30 and 40 dB (%30DB and %40dB), and mean depth ofdesaturation across all events with a 50% reduction/recovery ofairflow tidal volume (SpO2 dip).Results: 31 year-old male, 5 mm retrognathic at neutral setting.The overall and non-supine AI and AHI were unaffected.The supine AI reduced from 5 to 0 and the AHI by 40% to7 events/hr with increased VDO. The overall and supineSpO2 dip decreased from 3.2 to 2.3% and from 4.0 to 2.3%.Snoring%30dB increased from 19% to 42, and %40dB from 9to 30%.53 year-old male, 8 mm retrognathic at neutral. The number ofapnea events were minimal. The overall and supine AHI werereduced by 50% (to 9 and 5 events/hr respectively), and thenon-supine AHI by 30% to 13 events/hr with increased VDO.Snoring%@ 30dB increased from 48% to 62%, and %40dBfrom 48% to 55%.56 year-old male, 1 mm prognathic at neutral. The AI andAHI across and by position were < 5 events/hour with bothappliances. Increased VDO reduced snoring%30dB from 22%to 7%,54 year-old was 2 mm prognathic at neutral. He slept less than20 minutes in the supine position so no comparisons weremade. In the non-supine position, he averaged 7 events/hr witha SpO2 dip of 2.8% with the low and 5 events/hr and an SpO2dip of 2.4% with the high VDO. Increased VDO decreasedsnoring%30dB from 48% to 31%, and %40dB from 45% to25%.Conclusions: In some cases increased VDO increases snoringwhile reducing the AHI. This was not explained by increasedsnoring when apneas are converted to hypopneas. In othercases increased VDO reduces snoring without a change in SDBseverity. All four males preferred increased VDO.POSTER #008VALIDATION OF IMPORTANT SIGNS ANDSYMPTOMS OF SLEEP DISORDERED BREATHING(SDB) IN PATIENTS WITH TEMPOROMANDIBULARJOINT DISEASE (TMD)Prehn RS 1,4, Simmons JH 2, 3, 4 , Gray M 11Center for Facial Pain and Dental Sleep Medicine, PC, TheWoodlands, TX2Sadler Clinic Sleep Disorders Center, The Woodlands, TX3Comprehensive Sleep Medicine Associates , Houston, TX4Sleep Education Consortium, Houston, TXIntroduction: This is a follow-up study from last year wherewe demonstrated that 75% of all TMD patients have clinicalfindings to suggest the presence of SDB. The purpose of thisstudy is to not only to determine the prevalence of signs andsymptoms (S&S) in a busy TMD practice, but to validate theseS&S with PSG. We have previously postulated that the possibleetiology of clenching is a compensatory mechanism for acollapsing airway. Since clenching is a major etiological factorin TMD, then it would be reflected in the prevalence of otherS&S of SDB that would prompt a referral for a PSG in our TMDpatients.Method: We reviewed 580 cases referred to Facial Pain Clinicfor evaluation during 2009. We excluded all patients who didnot present with TMD as their chief complaint. We chartedthe major symptoms of SDB from their history and exam thatprompted a referral for a PSG. We then compared that to theS&S of the patients who complied with the referral to PSG.Results: There were 429 patients with TMD as their chiefcomplaint. There were 359 (84%) patients that were referred forPSG. Of these 359 patients, the following were the chief sleeprelated S&S that initiated the referral as compared to the S&S ofthose who had the PSG:TOTALREFERREDFrequentarousals359 TOTAL PSG 67272 76% Frequentarousals40 60%Bruxism 155 43% Morning 36 54%headachesMorningheadaches154 43% Bruxism 33 50%We Want Your Feedback | Visit www.aadsm.org/evaluations33

ABSTRACTSTakes ordesires naps119 33% Takes ordesires naps32 48%GERD 86 24% GERD 18 27%HBP 73 20% HBP 12 18%Witnessedapnea44 12% Blood sugarconcerns8 12%Blood sugarconcerns20 6% Witnessedapnea7 10%Of the 359 that were referred, 67 had the PSG completed .Non-compliance was for various reasons. 100% were found tobe abnormal and demonstrated SDB in the form of obstructiverespirations. Almost all of the studies were performed usingesophageal pressure monitoring (Pes) in order to reliablyidentify respiratory effort related arousals (RERA’s) such not tomiss the diagnosis of the UARS.Conclusion: This validation of the prevalence of S&S of SDBin TMD patients clearly indicates a significant relationshipbetween TMD and SDB. The prevalence of S&S of SDBin TMD patients clearly indicates a significant relationshipbetween TMD and SDB. This is confirmed and validated by thePSG on the patients who completed the study. With these andprevious results we postulate that the driving mechanism behindbruxing and clenching during sleep is a protective mechanismof an airway that has a propensity for collapsing, to prevent theobstruction from occurring. If this relationship does exist, thenit would be difficult to fully treat the entire clinical range ofTMD without addressing SDB. It is therefore recommended thatif patients present with TMD, one should screen for SDB andtreat that as well in order to address a major etiological factorcausing TMD in their patients.POSTER #009SIGNS AND SYMPTOMS OF SLEEP DISORDEREDBREATHING (SDB) IN PATIENTS WITH NOCTURNALBRUXISM (NB)Prehn RS 1,4, 2, 3, 4Simmons JH1Center for Facial Pain and Dental Sleep Medicine, PC, TheWoodlands, TX2Sadler Clinic Sleep Disorders Center, The Woodlands, TX3Comprehensive Sleep Medicine Associates , Houston, TX4Sleep Education Consortium, Houston, TXIntroduction: This is a follow-up study from last year wherewe demonstrated that 75% of all TMD patients have clinicalfindings to suggest the presence of SDB. Of those who hadNPSG testing, we found that clinical suspicion was correct100% of the time in our group tested. The purpose of this studyis to determine the prevalence of those signs and symptoms(S&S) in a subgroup of NB patients (based on exam andconfirmed at PSG). We have previously postulated that thepossible etiology of NB is a compensatory mechanism for acollapsing airway. If this relationship exists, then it would bereflected in the prevalence of other S&S of SDB at the initialexam of our TMD patients with NB.Method: We reviewed 580 cases referred to Facial Pain Clinicfor evaluation during 2009. We excluded all patients whodid were not diagnosed with NB at the initial exam. We alsoexcluded other patients with NB that were referred to a PSGat later follow-up appointments. The population for this studyincluded only the patients with NB who were referred for a PSGat the initial exam appointment only.Results: Out of the 580 patients, there were 155 patients seen atthe initial exam with NB that were referred directly for a PSGat that initial appointment. Of these 155 patients, the followingwere the chief sleep related S&S that initiated the referral:Bruxism 155 100%Frequent arousals 94 60%Morning headaches 75 48%Epworth over 8 65 42%Takes or desires naps 48 31%GERD 40 26%HBP 37 24%Witnessed apnea 26 17%Blood sugar concerns 12 8%Of the 155 that were referred, 65 were compliant with therecommendation to undergo NPSG testing. Non-compliancewas for various reasons. Of the 65 that had PSG studiesperformed, 100% were found to be abnormal and demonstratedSDB in the form of obstructive respirations. Almost all of thestudies were performed using esophageal pressure monitoring(Pes) in order to reliably identify respiratory effort relatedarousals (RERA’s) such not to miss the diagnosis of the UARS.NB was confirmed as well with EMG leads to the masseter,submental and temporalis muscles.Conclusion: The prevalence of S&S of SDB in NB patientsclearly indicates a significant relationship between NB andSDB. This is confirmed by the PSG on the patients whocompleted the study. This also supports the fact that there is ahigh correlation between SDB and NB. With these and previousresults we postulate that the driving mechanism behind bruxingand clenching during sleep is a protective mechanism of anairway that has a propensity for collapsing, to prevent theobstruction from occurring. It is therefore recommended that ifthere are S&S of NB, one should screen for SDB and treat thatas well in order to treat the entire clinical range of this disorder.34 We Want Your Feedback | Visit www.aadsm.org/evaluations

ABSTRACTSPOSTER #010DEVELOPMENT, IMPLEMENTATION ANDEVALUATION OF A CLINICAL PATHWAY IN AMULTIDISCIPLINARY DENTAL SLEEP MEDICINECLINICTen Berge DM 1 , Braem MJ 1, 2 , Altenburg A 1 , Vanhaecht K 4, 5 ,Van de Heyning PH 1, 3 , Vanderveken OM 1, 31Faculty of Medicine and Health Sciences, Antwerp University,Antwerp, Belgium 2 Special Care Dentistry Department,University of Antwerp and Antwerp University Hospital,Edegem, Belgium3ENT and Head and Neck Surgery Department, University ofAntwerp and Antwerp University Hospital, Edegem, Belgium4Centre for Health Services and Nursing Research, School ofPublic Health, Catholic University, Leuven, Belgium5European Pathway Association, Leuven, BelgiumIntroduction: Clinical pathways can be used as a method forquality improvement in health-care. They are used to organizecomplex and multidisciplinary care processes.The multidisciplinary approach of oral appliance (OA) therapyfor sleep-disordered breathing (SDB) is a complex and dynamicprocess in which constant monitoring and evaluation isimperative.Methods: A clinical pathway for patients referred for OAtherapy for SDB was developed at the Antwerp UniversityHospital and was instituted in January 2009. The clinicalpathway was developed using the 30-step method of the BelgianDutch Clinical Pathway Network, and, is referring to evidencebasedguidelines.Since the implementation of the clinical pathway over 300patients were included with integration of different diagnosticinvestigations and specific therapeutic actions.The aim of this study was to evaluate the impact of our clinicalpathway on the organization of the dental sleep medicineclinic using the Care Process Self Evaluation Tool (CPSET),a valid and reliable 29-item instrument. The CPSET has fivesubscales: patient-focused organization, coordination of care,communication with patients and family, cooperation withprimary care and monitoring/follow-up of the care process.Results: CPSET scores were assessed in a cohort of seventyninehealth care professionals involved in the multidisciplinarydental sleep medicine clinic.Overall, best scores were found concerning patient-focusedorganization (79.4 ± 12.1%) whereas lowest scores were presentfor cooperation with primary care (66.7 ± 12.4%). Based onsubgroup analysis for the different departments cooperatingwithin the clinical pathway, overall CPSET rates were noticedto be highest among the team at the Day Clinic while lowestoverall CPSET rates were noticed among the staff members ofthe Radiology department.Conclusion: This project is one of the first projects on pathwaysin OA and SDB. The development and implementation of aclinical pathway in our multidisciplinary dental sleep medicineclinic has created a huge dynamic between all participatingdisciplines. A first evaluation of the clinical pathway usingthe CPSET indicates that there clearly is room for furtherimprovement and that continuous monitoring is imperative.POSTER #011ORAL APPLIANCE TREATMENT OF OBSTRUCTIVESLEEP APNEA: PROGRESSION OF LONG-TERMSIDE EFFECTSPliska BT, Nam H, Chen H, Lowe AA, Almeida FRDepartment of Oral Health Sciences, Faculty of Dentistry, TheUniversity of British Columbia, Vancouver, CanadaIntroduction: Obstructive sleep apnea (OSA) often leads topoor sleep quality, daytime sleepiness, increased motor vehicleaccidents, hypertension and stroke. Oral appliances that holdthe mandible in a forward position and enlarge the airwaysduring sleep have increasingly been used for the treatmentof OSA. Though well tolerated, oral appliances have knownside effects, the most common being occlusal changes. AsOSA treatment continues throughout a patient’s lifetime, anexamination of the progression of these side effects over time iswarranted. Therefore the objective of this study was to evaluatethe progression of dental changes in patients after at least eightyears of oral appliance therapy.Methods: In this retrospective study, orthodontic study modelsof patients with records taken at least every four years, andwho were treated a minimum of eight years with a mandibularadvancement appliance for snoring or OSA were collected.Models were measured with a digital caliper, and valuesassessed included overjet, overbite, crowding, canine and molarposition, intermolar and intercanine distances. The rate ofchange for each variable was calculated and the data was thenstratified into 4-year treatment periods (years 0-4 of treatment,years 5-8, years 9-12, etc.) Method errors were calculated usingDahlberg’s formula. Descriptive measures, one-way ANOVAand Tukey’s post hoc tests were used to analyze the data.Results: A total of 77 patients (average age at start of treatment:47.5±10.2 years, 62 males) were included in this study. Theaverage treatment length was 11.1±2.8 years. Method errorfor dental measurements ranged from 0.13 to 0.64mm. Overthe total treatment interval evaluated there was a significant(p

ABSTRACTSsignificant, however overbite decreased at a significantly greaterrate (p>0.05) within the first four years of treatment beforestabilizing.Conclusions: Side effects of oral appliances appear to continueover time producing clinically relevant changes to the occlusionand dental arches. Overbite decreased most rapidly within thefirst four years of treatment, while all other occlusal changesoccurred at a consistent rate.Acknowledgements: Supported by a 2011 UBC UndergraduateStudent Summer Research Award, and by Klearway royaltiespaid to the University of British Columbia.POSTER #012ORAL APPLIANCE TREATMENT FOR PEDIATRICORTHODONTIC PATIENTS WITH OR WITHOUTSLEEP PROBLEMSChen H, Yagi K, Almeida FR, Pliska BT, Lowe AADepartment of Oral Health Sciences, Faculty of Dentistry, TheUniversity of British Columbia, Vancouver, CanadaIntroduction: The Klearway TM appliance was designed to openthe airway by gradual advancement of the mandible. It hasbeen used successfully for adult patients with mild to moderateobstructive sleep apnea and/or snoring. The orthopedic effectsof KlearwayTM on mandibular growth in pediatric patientswith Angle Class II, Division 1 malocclusions have not beeninvestigated. This prospective study assessed how KlearwayTMcould be utilized as a functional appliance for mixed dentitionpatients and how it would affect their breathing during sleep.Methods: Patients were selected to participate from theundergraduate orthodontic program at UBC. The study protocolwas approved by the UBC Ethics Committee. The inclusioncriteria were: Angle Class II Division 1 with a retrudedmandible, upright and well aligned mandibular incisors, a deepoverbite (>20%) and a deep overjet (≥4mm). The baseline dataincluded study models, cephalometric & panoramic X-rays,together with intra-oral & extra-oral photos. In addition, a sleepquestionnaire was administered at baseline. A customizedKlearway TM was fabricated for each patient and a portablesleep monitor (Watch-Pat) was used before the appliancewas inserted. Patients were advised to wear KlearwayTM atsleep time only. The patients were treated by monitoring and/or activating KlearwayTM on a monthly basis through to thePhase II comprehensive treatment stage. Follow-up records wereobtained to verify the craniofacial changes and sleep quality.Results: 50 patients (23 girls and 27 boys) have beenrecruited in this study. No patients discontinued therapydue to appliance discomfort. There are 20 patients (10 girlsand 10 boys) completed Phase I mixed dentition treatment.The average baseline age was 12 years 2 months. The meanduration of Klearway TM wearing was 14.5±8.7 months. TheAngle’s classification transitioned to Class I in 17 patients andClass III in 3 patients. The overjet was significantly decreasedfrom 7.0±2.4 mm to 3.0±2.3 mm (p

ABSTRACTSsectional area and its anteroposterior/transverse diameter ratiowere analyzed using three consecutive images at the level of theposterior nasal spine, the tip of the epiglottis, and the minimumcross-sectional area in both the velopharynx and retroglossalpharynx.Results: Significant decreases in the minimum cross-sectionalarea were found in the velopharynx when dentures were notworn when compared to the measurements taken when dentureswere present. However, there were no significant differences inthe anteroposterior/transverse diameter ratio.Conclusions: Our findings indicate that changes in the oralcavity dimensions during nasal breathing in denture wearersalter the pharyngeal cross-sectional area in the velopharynxwith the mandible in the postural position. Wearing denturesmay contribute to the maintenance of the pharyngeal airwayduring nasal breathing in denture wearers.Acknowledgements: Supported in part by a Grant-in-Aid forYoung Scientists Start-up (No. 20890122) and a Grant-in-Aidfor Challenging Exploratory Research (No. 21659445) from theJapan Society for the Promotion of Science (JSPS).POSTER #014THE REGULATION OF BREATHING ROUTE ANDSWALLOWING DURING SLEEP IN PATIENTS WITHSLEEP DISORDERED BREATHINGYagi K 1, 3 , Almeida FR 1 , Chen H 1 , Pliska B 1 , Ayas NT 2 , FleethamJA 2 , Lowe AA 11Department of Oral Health Sciences, Faculty of Dentistry, TheUniversity of British Columbia, Vancouver, Canada2Department of Respiratory Medicine, Faculty of Medicine,University of British Columbia, Vancouver, Canada3Department of Prosthodontics and Oral Rehabilitation, OsakaUniversity Graduate School of Dentistry, Osaka, JapanObjectives: The regulation of breathing route and swallowingduring sleep may be an important factor in patients with SleepDisordered Breathing (SDB). The aim of this study was todetermine the frequency of swallowing and its relationship tobreathing routes during sleep.Methods: Two 43-year-old male patients with SDB (bodymass index: 28.9 and 30.7 kg/m 2 ) were studied using standardpolysomnography. Breathing routes were evaluated with anasal pressure transducer and an oral flow thermistor sensor toclassify each 30-s epoch as nasal, oral or oro-nasal breathing.An oral and oro-nasal breathing epoch was defined as an epochcontaining at least one phasic signal on the oral thermistorsensor. Swallowing, evaluated with a piezoelectric sensor overthe thyroid cartilage and inductance plethysmograph on theribcage and abdomen, was defined as simultaneous signals ofan increasd chin EMG activity, transient interruption of airflow,movement of the thyroid cartilage and inspiratory effort.Results: The Apnea Hypopnea Indexes were 14.5 and 44.4.Total sleep times were 8.4 hours (WASO 10 min, Stage 1 8.5%,Stage 2 71.0%, Stage 3 0.1%, Stage 4 0%, REM 20.5%) and8.2 hours (WASO 16 min, Stage 1 9.7%, Stage 2 68.4%, Stage3 0.6%, Stage 4 0%, REM 21.2%). The total times classifiedas oral and oro-nasal breathing were 1.6 and 2.3 hours.Swallowing occurred 35 and 64 times during sleep. Frequenciesof swallowing were 9.5 and 15.1/hour during oral and oro-nasalbreathing and 2.9 and 5.0/hour during nasal breathing.Conclusions: Our findings suggest that patients with SDB maybreathe via an oral and oro-nasal route which exhibited a higherfrequency of swallowing during sleep. Further investigationson the regulation of breathing routes and swallowing in patientswith SDB are underway.Acknowledgements: Supported in part by MITACSACCELERATE BC.POSTER #015SLEEP BRUXISM-RELATED TOOTH WEAR ASA CLINICAL MARKER FOR PEDIATRIC SLEEP-DISORDERED BREATHINGSingh NTufts University, School of Dental Medicine, Craniofacial Pain,Headache and Sleep Center, Boston, MADr. Noshir Mehta (Professor and Chair)Introduction: The etiology of sleep bruxism has been debatedand researched extensively for several decades. While stillcontroversial, dento-occlusal and psychological (anxiety) factorsdo not enjoy scientific support in the etiology of sleep bruxism.Current research has suggested that sleep- disordered breathing,including obstructive sleep apnea-hypopnea syndrome(OSAHS) and upper airway resistance syndrome (UARS), maybe involved in the genesis of sleep bruxism. Children are atgreater risk of having sleep-disordered breathing than adultsdue to having a narrower upper airway. If untreated or notdiagnosed early, pediatric sleep-disordered breathing can resultin partial irreversibility of the neurocognitive, neurobehavioral,and cardiovascular damage seen with this condition. Theproblem lies with early diagnosis of pediatric sleep disorderedbreathing. This study aimed to investigate whether sleepbruxism-related tooth wear could be a clinical marker forpediatric sleep-disordered breathing, primarily, OSAHS.Methods: Fifty (50) pediatric subjects were recruited for thisstudy from a pediatric sleep disorder centre and a private dentalpractice. All subjects had undertaken either an attended orunattended overnight sleep study (polysomnogram) to diagnoseWe Want Your Feedback | Visit www.aadsm.org/evaluations37

ABSTRACTSthe presence of OSAHS. OSAHS was measured utilizing theapnea-hypopnea index (AHI) and the respiratory disturbanceindex (RDI). The AHI scored the OSA events, and was used toclassify the subjects into those with OSAHS and those with noOSAHS (controls; AHI0.05). However, there was astrong statistically significant association between the validatedRDI severity grade utilized in this study, and the presenceof dental wear (p

ABSTRACTSIntroduction: Sleep bruxism is a common condition causinghealth problems. It is found twice in population with sleepapnea and attention deficit hyperactive disorder. Stabilizingsplint (SS) is commonly used for treatment of sleep bruxism.The Nociceptive Trigeminal Inhibitory tension suppressionsystem (NTI-tss) is a new type of splint with partial coverageon incisor teeth. Evidences suggested that the NTI-tss occlusalsplint might be successfully used for the management of sleepbruxism. The objective was to assess the effect of the NTI-tsssplint on the sleep bruxism muscle activity, influenced to sleepvariables, airway obstruction, quality of life, and effect totempomandibular joint and masticatory muscles.Methods: Patients were recruited according to self-reported ofsleep bruxism 3 days or more per week. They were examinedat baseline and after each treatment period. The clinicianwho assessed the treatment was blinded for type of treatment.TMD and quality of life were assessed according to the RDC/TMD and the 14-item Oral Health Impact Profile questionnaire(OHIP-14), respectively. The overnight-in-laboratorypolysomnography was used to record baseline data of sleepvariables and electromyographic (EMG) activity of massetermuscle in the second night. Patients were randomly assignedto wear each type of splints for 2 weeks with 2-week apartaccording to cross-over design. At the end of each treatment,patients wore the splint for polysomnographic recording. Sleepvariables was analysed according to Rechtschaffen and Kales.The criteria for classify sleep bruxism followed Lavigne andcoworkers. Shapiro-Wilk tests and normal plot were used toscreen for a normal distribution. ANOVA statistic and Tukey-Kramer statistics were used when data was normal distributedwhereas Kruskal-Wallis test and Dwass-Steel-Critchlow-Flignerstatistics were used when data was not normal.Results: Ten patients (8 female and 2 male; age 22-43 years)were participated. The sleep efficiency of NTI-tss splintwas reduced significantly compared with baseline (92.3±1.7,95.7±0.5; p = 0.03). Sleep stage 3 & 4 of SS-splint was decreasedcompared with baseline (10.7±2.3, 5.3±2.2; p = 0.05). Nochanges in respiratory events were observed. The sleep bruxismepisode per hour of NTI-tss, SS splint and baseline were notsignificantly different (2.38±0.47, 1.85±0.21, 1.71±0.23; p = 0.4).The duration of sleep bruxism episode of SS splint (4.8±0.35)was longer than baseline (3.2±0.2, p = 0.0002) and NTI-tss(3.2±0.15, p < 0.0001). The mean number of muscle activitiesin an episode of NTI-tss was less than SS splint (3.8±0.1,5.2±0.3; p= 0.0016). The frequency of burst of muscle activityof SS splint (1.22±0.04) was less than baseline (1.36±0.05, p =0.01) and NTI-tss (1.38±0.05, p = 0.01), respectively. The EMGactivity of NTI-tss (39.8±1.7) was remarkably less than SS splint(86.4±2.8; p < 0.0001) and baseline (73.3±2.5; p < 0.0001). Theduration of muscle activity of NTI-tss (1.87±0.14) is shorterthan SS splint (3.0±0.19; p < 0.0001) and baseline (2.06±0.09;p = 0.01). Almost all of sleep bruxism episodes were classifiedas phasic type. There were no difference in temporomandibularjoint sound and range of movements after treatment withboth splints. The number of muscle pain on palpation weresignificantly reduced in NTI-tss group (p = 0.045). The qualityof life measuring with OHIP-14 at pre- and post-treatmentamong 3 groups were not significantly different. The level ofcomfortable of both splints was not significantly different ( p= 0.43) even though there was tendency that the comfortablelevel of SS splint (62.3±12.4) was higher than NTI-tss splint(49.5±10.3). NTI-tss significantly caused more salivation thanSS splint (p = 0.047). The self-reported of neck pain wassignificant reduced with SS-splint (p = 0.03).Conclusions: This short term study indicated a stronginhibitory effect on EMG activity of elevated masticatorymuscle of the NTI-tss splint but not the SS splint. Both splintswere not reduced sleep bruxism episodes. Sleep patternsseemed to be altered with both splints. There were no significantchanges in respiratory events when wearing both splints. Therewere no adverse serious side effects with both splints. NTI-tssmay alleviate masticatory muscle pain.Support: This research project was funded by Prince ofSongkla University and Thanes company Thailand.POSTER #018A NOVEL THERAPY APPROACH FOR SLEEPBRUXISM IN CHILD WITH CEREBRAL PALSY -LONG TERM FOLLOW-UPGiannasi LC 1,2 , Batista SRF 1 , Hardt CT 1 , Matsui MY 1 , GomesCP 1 , Amorin JBN 1 , Oliveira CS 2 , Oliveira LVF 2 , Gomes MF 11São Paulo State University “Julio de Mesquita Filho” - UNESP/SJC2Nove de Julho University-UNINOVEIntroduction: Among various oromotor alteration arisingfrom CP, sleep bruxism is very prevalent in this population in arange of 25-32.8%. Few studies was found using a masticationapparatus -hyperbola (HB) in odontology, and none wasfound describing its usage to treat sleep bruxism, in normal ordisabilities individuals. The aim of this study was to evaluatethe effect of the HB in reducing sleep bruxism and electricalactivity of jaw-closing muscle in a child with cerebral palsy bythe surface electromyographic (EMG) analysis after one weekand 09months of HB usage.Methods: A 07 years-old boy, with severe spasticity CP andsleep bruxism presented for treatment to the Departmentof of Biosciences- Special Care Needs at State of Sao PauloUniversity- UNESP- Brazil. The reasons to search forspecialized professional care were the severe tooth wear andloud noises resulting from sleep bruxism, witnessed by hismother, even when she was at another room. Child did notWe Want Your Feedback | Visit www.aadsm.org/evaluations39

ABSTRACTSaccept undergo the polysomnography, only a adapted sleepquestionnaire was applied. Therapy with HB was performedfor 05 minutes, 06 times a day, during one week. Surface EMG,on mandibular rest and maximum contraction position, werecarried out on left and right masseter and temporalis ( LM, RM,LT,RT) muscles bilaterally to evaluate its electrical activity,prior and 1 week of HB usage.Results: After HB usage, parents reported a significantreducing of tooth grinding during sleep. In addition, it hasimproved the salivary incontinence in awake times, andsucking-swalling movement during meals. After one week osHB therapy, EMG on mandibular rest position decreased from537.7 to107.7 on RM; rose from 44.0 to 107.7 on LM; decreasedfrom 257.3 to 111.7 on RT; rose from 7.4 to 18.0 on RT. EMGfor isometric position values decreased from 1102.0 to 540.0on RM; decreasing from 189.0 to 152.0 on LM; decreasingfrom 414.0 to 225.0 on RT; rising from 1.2 para 30.4 on LT.After 09 months, the values for rest and isometric positionwere: RM=106.0/274.0; RT=96.0/224.0; LM=130.0/168.0;LT=114.0/228.0, respectively.Conclusion: Hyperbola was efficient to treat sleep bruxismin this case and its usage has lead to a visible tendency toreorganization of dynamic masticatory, achieving markedbalance on electrical activities of jaw-closing muscles,improving child quality of life, even after 9 months. Thistherapy may be considered due to its promising effects and lowcost-benefits, which allow its use in a public health policy toachieve a better quality of life for cerebral palsy individuals. Astudy with a larger sample is needed to validate these results.POSTER #019CLINICAL MANAGEMENT OF SLEEP BRUXISM INA CHILD: A CASE REPORTAlfaya TA 1 , Uemoto L 1 , Depes Gouvêa CV 1 , Bortoletto CC 1 ,Motta LJ 1 , Giannasi LC 1,2 , de Oliveira LVF 1 , Bussadori SK 11Nove de Julho University - UNINOVE, São Paulo, SP, Brazil.2State of Sao Paulo University “Julio de Mesquita Filho” -UNESP/SJC, São Paulo, SP, BrazilSleep bruxism is an unusual orofacial movement described as aparafunction in odontology and as a movement disorder in sleepmedicine. It is characterized by tooth grinding or clenching.Clinically, it is associated with abnormal tooth wear and jaw/muscle discomfort. The aim of this paper is to report the caseof a 7-year-old male patient who attended the Pain Clinic ata higher educational institution with the main complaint ofheadache in frontal and temporal region presenting duringthe three last months (pain categorized as moderate in facescale). Mother related that the child presented tooth grindingduring the sleep. The physical examination revealed toothwear and pain during the muscular palpation. There wereno joint alteration. In muscle palpation, moderate pain wasobserved in the anterior and middle temporal, masseter andsternocleidomastoid muscles bilaterally. We also observed signsof anxiety such as restlessness and hyperactivity. The diagnosisof sleep bruxism was based on the report of her mother andthe dental changes observed. The adopted therapy was theconstruction an acrylic resin splint with occlusal adjustmentsmade every fifteen days in order to do not to impair bonegrowthing and eruption of permanent teeth. The patient wasinstructed to use the occlusal splint during the day and nightfor a week. In the second week, the orientation was to use thesplint only to sleep. Moreover, the patient was referred to thepediatric dentistry clinic to oral treatment and encouraged toseek psychological care. After a week of using the splint, thepatient reported no episodes of headache and during physicalexamination there was observed no pain for all muscles in thehead and neck region. Evaluation were performed after 15 and21 days, and there was remission of painful symptoms. Thepatient remains under dental and physiological care. In thiscase, the occlusal splint was efficient in reducing the symptomsof orofacial pain. A periodic attendance is necessary to establishin what moment we discontinue the use of splint. A Sample witha greater number is needed to validate the results.POSTER #020EFFECTIVENESS OF ORAL APPLIANCES IN THETREATMENT OF OBSTRUCTIVE SLEEP APNEAFirestone AR, Jones E, Delli-Gatti R, Beck FM, Magalang UThe Ohio State University, Columbus, OHIntroduction: The efficacy of oral appliances in the treatmentof obstructive sleep apnea is well documented. However, thereare few reports of the effectiveness of oral appliances in clinicalpractice. Aims: To report the results of quality improvementefforts and highlight the results of the use of oral appliances inone private practice.Methods: As part of a quality improvement exercise,consecutive patients who received an oral appliance for thetreatment of obstructive sleep apnea in the time period July 1,2009 to June 30, 2011 were included in the study. Patients weretreated in a private practice setting within a college of dentistry.Ninety patients received an oral appliance in that time period.Results: Twenty-one subjects had follow-up polysomnogram(PSG) studies. From dental and medical records initial andfollow-up apnea-hypopnea index (AHI) and initial and followupEpworth Sleepiness Scale (ESS) scores were recorded. Themean initial AHI value was 22.8, and ESS score 9.7. For those21 patients with follow-up PSG studies, mean initial AHI valuewas 28.3 and ESS score was 10.7, the AHI at follow-up was 8.3and the ESS score was 6.6.The follow-up rate was low, 23%, but some patients had notbeen clinically titrated with their oral appliance yet, andtherefore had not been sent for a follow-up sleep study, so the40 We Want Your Feedback | Visit www.aadsm.org/evaluations

ABSTRACTSrate should increase. For those who presented for a follow-upstudy, the reduction in AHI was approximately 70% and for theESS score, approximately 32%. Sixteen, 76%, of the 21 patientshad an AHI below 10.0 at follow-up.Conclusions: With regard to quality improvement, thefollow-up rate was low but may reflect actual practice morethan university or hospital based efficacy studies. However,the success rate, in terms of reduction of AHI below 10, orpercentage reduction in AHI does reflect values reported in theliterature.mean percentage of days used was 90.1 ± 12.2% (range 64.6-100). The mean average daily use on days used was 6.2 ± 1.2 hr(range 4.9-7.9). The device was well tolerated by the subjects.Conclusions: Patient adherence to oral mandibularadvancement device treatment of OSA can be objectivelyassessed with an imbedded temperature sensor. The particulartemperature sensor used in this study was relatively easy to usebut was limited by its storage capacity.POSTER #021MONITORING ADHERENCE TO ORALMANDIBULAR ADVANCEMENT DEVICETREATMENTAbrams E 1 , Bogen DK 2 , Kuna ST 3,41Princeton Park Dental Associates, PA, Princeton, NJ, USA;University of Pennsylvania School of Dental Medicine2Department of Biomedical Engineering, University ofPennsylvania, Philadelphia, PA3Department of Medicine, University of Pennsylvania,Philadelphia, PA4Philadelphia VA Medical Center, Philadelphia, PAIntroduction: One of the barriers preventing wider acceptanceof oral mandibular advancement device treatment of patientswith obstructive sleep apnea (OSA) has been the inability toobjectively monitor patient adherence to this treatment. Weevaluated the feasibility of using of a commercially availabletemperature sensor (DS1921 Thermochron® iButton®)imbedded in the oral device to obtain this information.Methods: Seven adults (2 females) who were already usingan oral appliance (EMA®) for treatment of their OSA wereenrolled. The mean (SD) AHI on their diagnostic sleep studywas 23.3 ± 15.2 events/hr. The stainless steel temperaturesensor disk (5.89 mm width, 16.25 mm diameter) was imbeddedinto a new EMA® device on the posterior, buccal side of theupper dental arch tray. Patients were aware of the purpose of thesensor and advised to wear the appliance whenever they slept.The temperature sensor was programmed to make recordingsevery 20 minutes resulting in a storage capacity of 21 days.Downloads of the recorded data were obtained during officevisits over a 3 month period by touching the sensor with metalprobes.Results: Of the 94.6 ± 16.5 (range 82-129 days of observation,data were available for 80.6 ± 10 days (range 60-91). Loss ofdata was due to the sensor becoming dislodged from the device(n=2), failure of the download (n=3), failure of the patient toreturn within 3 weeks resulting in the sensor overwriting data(n=2). Based on the number of days data were available, theWe Want Your Feedback | Visit www.aadsm.org/evaluations41

SPEAKER INDEXNancy Addy, DDS, Diplomate, ABDSM graduated from theUniversity of Missouri School of Dentistry in 1988 where sheattended a year residency in Advanced Education in GeneralDentistry. During her 21 years in dentistry, Dr. Addy taught atUMKC for 9 years as Assistant Professor of Clinical Dentistrywhere she was head of the Esthetic and Cosmetic DentistryDepartment. Dr. Addy developed an interest in treatingpatients with snoring, obstructive sleep apnea and CPAPintolerance which led to becoming a credentialed diplomate ofthe American Academy of Dental Sleep Medicine. Dr. Addynow serves on the American Board of Dental Sleep Medicine.She continues to increase her knowledge and commitment inthe treatment of apnea and snoring, working with intra-oralappliances in OSA and snoring management.Fernanda Almeida, DDS, PhD, Diplomate, ABDSM isa clinical assistant professor at the University of BritishColumbia. She has been involved in oral appliance researchand the treatment of patients with obstructive sleep apnea since1996.Sonia Ancoli-Israel, PhD is a Professor in the Departmentsof Psychiatry and Medicine at the University of California SanDiego (UCSD) School of Medicine, Director of the Gillin Sleepand Chronomedicine Research Center, Director of Education atthe Sleep Medicine Center at UCSD and Deputy Director of theUCSD Stein Institute for Research on Aging. Dr. Ancoli-Israel’sexpertise is in the field of sleep disorders and sleep research inaging.Richard Berry, MD is Professor of Medicine at the Universityof Florida, Gainesville Florida. He is medical director of theUF & Shands Sleep Disorders Center and program directorof the UF Sleep Fellowship. He served as the President of theAmerican Sleep Medicine Foundation and on the board ofdirectors of the American Academy of Sleep Medicine. Dr.Berry is an Associate Editor for the Journal of Clinical SleepMedicine and is a current member of the AASM AcademicAffairs Committee.Douglas Bradley, MD is Professor of Medicine and Director,Division of Respirology at the University of Toronto, theCardiopulmonary Sleep Disorders and Research Centre at theToronto General Hospital/University Health Network, andthe Sleep Research Laboratory at the Toronto RehabilitationInstitute. Dr. Bradley completed his MD degree at theUniversity of Alberta in Edmonton in 1978. Subsequently, hecompleted specialty training at the University of Toronto inInternal Medicine in 1982 and Respirology in 1985. Followingcompletion of clinical training he went on to 3 years of researchtraining in sleep apnea and respiratory muscle physiology atthe University of Toronto and McGill University, respectively.He has been on staff at the Toronto General Hospital at theUniversity of Toronto since 1985. His clinical and researchwork focuses on the relationship between sleep apnea andcardiovascular diseases, with a particular focus on thepathophysiology and treatment of sleep apnea in patients withheart failure. He holds several peer-reviewed grants from theCanadian Institutes of Health Research (CIHR), The Physicians’Services Incorporated and the Heart and Stroke Foundation ofOntario. He has published over 140 papers and book chapters onsleep apnea and related topics. Dr. Bradley is a member of theAmerican Society for Clinical Investigation and is an AssociateEditor of the American Journal of Respiratory and Critical CareMedicine, and is on the editorial board of SLEEP.Kelly Carden, MD is board certified in Internal Medicine,Pulmonary, Critical Care Medicine and Sleep Medicine. Shenow devotes 100% of her time to the field of sleep medicine.Dr. Carden earned her undergraduate degree from VanderbiltUniversity and both her medical degree and masters of businessadministration (MBA) from the University of Tennessee. Shecompleted an internal medicine residency program at BaylorCollege of Medicine in Houston and completed her fellowshiptraining including her sleep medicine fellowship at HarvardMedical School. She is a nationally known speaker, sleepmedicine course director, and author and is considered to bea thought leader in the field of sleep medicine. She joined StThomas Health and Sleep Medicine of Middle Tennessee inMarch 2011.Michael Decker, PhD, RRT received his PhD in Anatomyand Neuroscience from Case Western Reserve University.He received his certification (D. ABSM) from the AmericanBoard of Sleep Medicine and is also a Registered Nurse and aRegistered Respiratory Therapist. Dr. Decker’s research focusesupon sleep-related disorders, their etiology and corollaryneurochemical, cognitive, and behavioral sequela. Dr. Deckercurrently holds the Byrdine F. Lewis endowed chair in Nursingat Georgia State University. Prior this he was an AssistantProfessor of Neurology at Emory University (2000-2007)and a Visiting Scientist at the Centers for Disease Control &Prevention (2003-2012).B. Gail Demko, DMD, Diplomate, ABDSM received her DDSfrom Boston University and was a hospital-based dentist atBeth Israel Deaconess Medical Center in Boston for 20 years.In 1997, she limited her dental practice to the treatment of OSAand is an expert advisor to the FDA on oral appliance therapy.She serves on the AADSM Board of Directors.Leslie Dort, DDS, Diplomate, ABDSM graduated with a DDSfrom the University of Western Ontario in 1980. Although shehas practiced general dentistry in both urban and rural locationsin Canada, her work is now entirely focused on sleep. She isa member of the University of Calgary faculty of medicinewhere she is engaged in research focused on the diagnosis andtreatment of sleep disordered breathing.42 We Want Your Feedback | Visit www.aadsm.org/evaluations

SPEAKER INDEXBarbara C. Fisher, PhD, CBSM is a Psychologist/Neuropsychologist, board certified in behavioral sleepmedicine and she is the founder and Clinical Director of UnitedPsychological Services. Trained as a neuropsychologist, Dr.Fisher has spent much of her time assessing and studyingchildren to understand how the presence of various disorderssuch as ADD/ADHD, Autism, TBI and other brain disordersaffects their ability to learn and function. Dr. Fisher developeda school program, Fisher Academy with the goal of encouraginglearning based upon frontal lobe principles to help childrendiagnosed with autism and frontal lobe disorders.Bernard Fleury, MD is currently running the sleep disorderscenter of the Hôpital Saint-Antoine, Groupe Hospitalier Paris-Est-Université Pierre et Marie Curie, Paris, France. He worksclosely with the ENT department and with the Orthodonticsdepartment of the faculty. He is engaged on research andpublications focused on treatment of obstructive sleep apnea inadults, CPAP therapy, surgery and oral appliance.Patrick Hanly, MD, FRCPC, Diplomate, ABSM is currentlyMedical Director of Foothills Sleep Centre and Professor ofMedicine at the University of Calgary, Alberta, Canada. Heis a physician, trained in Respiratory Medicine and SleepMedicine. In addition to running a clinical practice, he hasan active research program in sleep medicine with a majorinterest in the cardiovascular complications of sleep apnea,the interaction between sleep apnea and co-morbid diseaseincluding heart failure and kidney failure, and the investigationof new strategies to treat sleep apnea. He has published almost100 peer-reviewed papers in addition to several reviews andbook chapters.Eliot Katz, MD is an assistant professor of pediatrics atHarvard Medical School, and practices at the Center forPediatric Sleep Disorders at Children’s Hospital Boston. Hespecializes in pediatric sleep disorders and the pathophysiologyof obstructive sleep apnea, particularly associated withchildhood obesity. Dr. Katz received his medical degree atMcGill University in Montreal, and completed his pediatricresidency with the University of California at Irvine.Christopher Lettieri, MD is an Army medical director and thechief of sleep medicine in the pulmonary, critical care and sleepmedicine department at Walter Reed National Military MedicalCenter in Washington, DC.Kasey Li, DDS, MD, FACS is certified by the Americanboards of otolaryngology, oral and maxillofacial surgery, aswell as facial plastic and reconstructive surgery. Based on hisunique background and experience, Dr. Li has pioneered andrefined many sleep apnea surgical techniques. Dr. Li is thesurgical consultant to numerous sleep disorder centers. He haspublished more than 100 scientific articles and book chapterson sleep apnea surgery and maxillofacial surgery. Dr. Li has,by invitation, lectured widely throughout the United States andabroad as an internationally recognized expert in sleep apneasurgery.Gila Lindsley, PhD has a PhD in Physiological Psychologyfrom the University of Wisconsin, did her internship insleep disorders medicine at the Dartmouth-Hitchcock sleepdisorders center, and is a fellow of the American Academyof Sleep Medicine. The founding director of one of the firstsleep disorders centers in New England, established in 1983,she has maintained a private practice sleep disorders clinic inLexington, MA since 1992. She is a member of the MedicalAdvisory Board of Narcolepsy Network with considerableinterest in narcolepsy. Of particular interest to her are sleepdisorders in a school age population, and circadian rhythmdisturbances across the age span.Alan Lowe, DMD, PhD, Diplomate, ABDSM is Professor andChair of the Division of Orthodontics in the Faculty of Dentistryat The University of British Columbia. His extensive researchcontributions on the use of oral appliances for the treatmentof snoring and Obstructive Sleep Apnea and their effects onairway size and tongue muscle activity have been recognizedworldwide. In addition, he holds Canadian, USA and worldwideindependent patents for three technologies related to hisresearch endeavours.Marie Marklund, DDS, PhD is Associate Professor of theDepartment of Odontology, Medical Faculty, Umeå University,Sweden and is the head of the Orthodontic Department.She works in collaboration with the Sleep Apnea Clinic atthe Department of Respiratory Medicine, Umeå UniversityHospital. Her practice focuses mainly on the treatment ofpatients with snoring and obstructive sleep apnea (OSA) withoral appliance therapy (OAT).James Metz, DDS, Diplomate, ABDSM is a 1973 graduateof The Ohio State University College of Dentistry. Dr. Metzmaintains a general dental practice in Columbus, Ohio with anemphasis on dental sleep medicine, TMD and reconstructivedentistry. He is the Assistant Director of The Ohio StateUniversity Medical Center Sleep Medicine Fellowship Program.He serves on the AADSM board of directors and Ohio SleepSociety board of directors. Dr. Metz is the chair for theIntroductory Course of Dental Sleep Medicine for the AADSM.He is a Diplomate of the ABDSM and holds memberships inthe ADA/ODA, American Academy of Restorative Dentistry,American College of Dentists, AADSM, EADSM and otherorganizations. He is the mentor for several dental study groups.William Orr, PhD is a Diplomate in the American Board ofSleep Medicine. He is currently President Emeritus and SeniorScientist at the Lynn Health Science Institute and ClinicalWe Want Your Feedback | Visit www.aadsm.org/evaluations43

SPEAKER INDEXProfessor of Medicine at the University of Oklahoma HealthSciences Center. Dr. Orr has published extensively on a widevariety of topics in sleep medicine. His publications includesome of the initial descriptions of sleep apnea syndrome andits pathophysiology. His research interests include sleep andgastrointestinal disorders, autonomic function during sleep, andsleep related respiratory disorders.Robert Owens, MD received his medical degree from theColumbia University College of Physicians and Surgeons.He completed training in Internal Medicine, Pulmonary andCritical Care Medicine at Massachusetts General Hospital andthe Harvard Combined Program in Pulmonary and CriticalCare. His research interests subsequently led to basic respiratoryphysiology and Sleep Medicine. Currently, he attends in themedical intensive care unit of the Brigham and Women’sHospital, as well as in the BWH-affiliated Sleep HealthCentersin Brighton, MA. As part of the White/Malhotra laboratory,Dr. Owens seeks to understand what different factors lead toOSA in a given subject. The overall aim of the research is toidentify personalized treatment regimens for patients with OSA.His research is funded by the National Heart, Lung, and BloodInstitute.Jan Palmer has been involved in the field of dentistry since1982. In 1999 she accepted a position with a Diplomate of theAmerican Board of Dental Sleep Medicine (ABDSM) andbegan to learn about the medical insurance industry and how tomaximize insurance benefits for dental sleep medicine. She hassince formed her own consulting business for training dentaloffices on how to properly understand the medical insuranceworld for treatment of obstructive sleep apnea with oralappliance therapy to maximize the patient’s benefits.Benjamin Pliska, DDS, MS, FRCD(C) is an assistantprofessor in the Division of Orthodontics at the Universityof British Columbia and maintains a private practice inorthodontics in Vancouver, BC. Dr. Pliska obtained his DDSfrom the University of Western Ontario and both his Master’sdegree and Orthodontic Certificate from the University ofMinnesota. A Fellow of the Royal College of Dentists of Canadaand a Diplomate of the American Board of Orthodontics, Dr.Pliska also recently earned a Graduate Certificate in PediatricSleep Science from the University of Western Australia. Dr.Pliska’s research interests include dentofacial imaging andthe orthodontic and orthopedic treatment of pediatric sleepdisorders, while being an active member of UBC’s sleepresearch team.Thomas Roth, PhD is the founder of the Sleep Disordersand Research Center at the Henry Ford Hospital in Detroit,Michigan, and has been the director since 1978. Dr. Roth isalso a professor in the department of psychiatry at Wayne StateUniversity, School of Medicine in Detroit, Michigan, and servesas a clinical professor in the department of psychiatry at theUniversity of Michigan, College of Medicine in Ann Arbor. Dr.Roth’s research focuses on both normal as well as pathologicalsleep processes. His work includes research on sleep loss, sleepfragmentation, and deviation from normal sleep processesincluding pharmacological effects and sleep pathologies. Hisresearch on insomnia underscores the breadth of his research.He published on the epidemiology, pathophysiology, diagnosis,comorbidity with other disorders and treatment of insomnia.Steven Scherr, DDS, Diplomate, ABDSM is a graduate of theUniversity of Maryland School of Dentistry and a Diplomate ofthe American Board of Dental Sleep Medicine (ABDSM). Heis a private practice general dentist providing oral therapeuticsfor the treatment of sleep apnea, snoring, facial pain, andtemporomandibular disorders.Susanne Schwarting, DDS, Diplomate, ABDSM is a dentistin Kiel, Germany, with a practice limited to dental sleepmedicine. She is a diplomate of the American Board of DentalSleep Medicine, founding member and president of the GermanSociety of Dental Sleep Medicine and founding member and onthe board of the European Academy of Dental Sleep Medicine.She lectures internationally to sleep physicians and dentistson the dental treatment of sleep disordered breathing and isa founding member/supporter of workgroups on dental sleepmedicine throughout Europe. Dr. Schwarting serves on theeditorial board of the journal Sleep & Breathing. Since 2011, shehas lectured on dental sleep medicine at the dental school of theUniversity of Greifswald. In September 2012, she will introducedental sleep medicine at the FDI Annual World Dental Congressin Hong Kong.Lydia Sosenko, DDS, Diplomate, ABDSM received herdental degree from the University of Illinois in Chicago Dentaltraining from the University of Illinois in Chicago. She enteredthe world of dental sleep medicine in 1998. Dr. Sosenko is aDiplomate of AADSM and has limited her practice to dentalsleep medicine while maintaining a general dental practice.Dr. Sosenko is passionate in reaching a neglected populationof snoring and apnea sufferers with the use of her creativity,leadership training and postdoctorate training in businessdevelopment and coaching. In 2012, Dr. Sosenko’s generaldentistry practice was awarded a prestigious small businessaward in her community. Dr. Sosenko is devoted to the wellbeingof her patients and communication with her referringmembers of the medical and dental fields, as well as workingwith business owners and leaders who want strategies to besuccessful as they move towards excellence.R. Bruce Templeton, DMD is a board-certified oral andmaxillofacial surgeon who is currently chief of oral surgeryand dentistry at the Veteran’s Affairs Hospital in Minneapolis,44 We Want Your Feedback | Visit www.aadsm.org/evaluations

Minnesota. He holds the rank of clinical professor at theUniversity of Minnesota Faculty of Dentistry.Olivier M. Vanderveken, MD, PhD is currently a full-timestaff member ENT, Head and Neck Surgeon at the AntwerpUniversity Hospital in Belgium. He is also appointed as aFaculty Lecturer and as a part-time teacher and instructor atthe Clinical Skills Laboratory, both at the Faculty of Medicineof the University of Antwerp. Dr. Vanderveken receivedhis medical degree from University of Antwerp in 2001.He completed an ENT, Head and Neck Surgery residencyat Middelheim and Antwerp University Hospital. In 2007,he obtained a PhD in Medical Sciences on the topic of thefundamental and multidisciplinary approach to upper airwaycollapse during sleep disordered breathing. His main researchis in the area of sleep disordered breathing, in particulardrug-induced sleep endoscopy, treatment of sleep apnea withmandibular advancement devices and upper airway surgeryincluding hypoglossal nerve stimulation and transoral roboticsurgery. Dr. Vanderveken has co-authored several professionalpublications and is on the editorial board of the journal Sleep &Breathing.Chicago, Illinois, where she is also Associate Director of theCenter for Sleep and Circadian Biology.Dr. Zee directs an interdisciplinary clinical and researchprogram in sleep and circadian rhythms. Research topics inthis Program range from basic animal studies to therapeuticclinical trials. Her research has focused on the effects of ageon sleep and circadian rhythms, genetic regulation of circadiansleep disorders, and behavioral interventions to improve sleepand performance. Dr. Zee also has authored more than 100 peerreviewed original articles and over 40 chapters and reviews onthe topics of sleep, circadian rhythms, and sleep/wake disorders.A fellow of the American Academy of Sleep Medicine, fellowof the American Academy of Neurology and member of theAmerican Neurological Association, Dr. Zee has served onnumerous national and international committees, NIH scientificreview panels, and advisory boards. She is President of theSleep Research Society, past Chair of the NIH Sleep DisordersResearch Advisory Board, and A Deputy Editor for the journalSLEEP. Dr. Zee was honored with a Sleep Academic Awardfrom the National Institutes of Health to enhance educationin sleep medicine and is the recipient of the 2011 AmericanAcademy of Neurology Sleep Science Award.Sigrid Veasey, MD received her BS in Biochemistry atSweet Briar College, and her MD from the University ofVirginia. As an associate professor of medicine at Universityof Pennsylvania, Dr. Veasey has developed a major programof research on oxidative injury neurons in murine models ofobstructive sleep apnea (OSA), work that is ready for clinicaltranslation. Dr. Veasey’s laboratory focuses on neural injuryincurred by hypoxia/reoxygenation events of obstructive sleepapnea. Through her current research, Dr. Veasey hopes toidentify the optimal overall pharmacotherapeutic approach toprevent or minimize neural injury in sleep apnea.Edward Weaver, MD is a staff surgeon on the surgery serviceof the Department of Veterans Affairs Medical Center and anassociate professor of otolaryngology and the chief of sleepsurgery at the University of Washington, both in Seattle,Washington. He obtained his medical degree at Yale andcompleted his otolaryngology residency at Yale. He obtainedhis masters degree in public health (health services research)and completed a clinical research fellowship at the Universityof Washington. He is board certified in otolaryngology/head& neck surgery and in sleep medicine, and he practices thefull range of sleep apnea surgery. He has an active clinicalresearch program studying sleep apnea, and he is involvedinternationally in policy, research, and clinical activities in sleepsurgery.Phyllis Zee, MD, PhD is Professor of Neurology, Neurobiology& Physiology, and Director of the Sleep Disorders Centerand the sleep medicine fellowship training program, atNorthwestern University’s Feinberg School of Medicine inWe Want Your Feedback | Visit www.aadsm.org/evaluations45

AADSM 21ST ANNUALMEETING SPECIALPackage discounts available at the AADSM Annual Meeting only!PATIENT EDUCATION PACKAGE• Oral Appliance Therapy: A Patient Education DVD• Variety Pack, 6 Posters (8.5 x 11)• Patient Education Brochures (1 Pack Each)- Treatment of Snoring and Obstructive Sleep Apnea- Oral Appliance Therapy for Snoring and Obstructive Sleep Apena- Oral and Maxillofacial Surgery for Snoring and Obstructive Sleep Apnea- Dental Sleep Medicine and Insurance Reimbursement- Teen Drowsy DrivingSAVINGSOF 30%Regular $235.00Special $165.00

The American Academy of Dental Sleep Medicine acknowledges and thanksthe following companies for their participation in the 2012 Sponsorship Program. Theirgenerous support contributes to the advancement of dental sleep medicine education, research andclinical practice.PLATINUMhenry schein DentALnierMAn prActice MAnAGeMentoAsys orAL nAsAL AirwAy systeMsLeep optiMA, LLcsoMnoMeDstronG DentALGOLDAirwAy Metrics LLcDentAL services GroupMyerson/FrAntz DesiGnspAce MAintAiners LAborAtorySILVERAirwAy MAnAGeMentDentAL prosthetic servicespM-Assist® sLeep scorinG AnDinterpretAtion serviceAMERICAN ACADEMY of DENTAL SLEEP MEDICINEDFDental Sleep M e DicineFacility accreDitationIllustrating Quality in the Standards of Dental Sleep Medicine through proficiency, practice & professionalism.In an effort to safeguard patient care and promote appropriate treatment protocols for the use of oralappliance therapy and upper-airway surgery for the treatment of sleep-related breathing disorders,the AADSM has developed an accreditation program for dental sleep medicine facilities.Members of the AADSM are encouraged to initiate the process of accrediting their facilitynow. Learn more about this program and review the Standards for Accreditation of Dental SleepMedicine Facilities on the AADSM website at www.aadsm.org.

Photos Courtesy of Visit Baltimore